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ABSTRACT
Cumulative evidence indicates thai the release of spinal prostaglandins
(PGs) is increased in hyperalgesia and persistent pain states following peripheral
inflammation or injury, events thai are associated with repetitive C-fiber stimulation.
Non-steroidal anti-inflammatory drugs (NSAIDs), given intrathecally (i.t.), inhibited
PG release and attenuated persistent pain and hyperalgesia, approximately 500-
1000 more potently when compared with systemic administration suggesting a
central site of action. CycloQxygenase (COX), the enzyme for PG synthesis, is
present in the spinal dorsal horn where the nociceptive C-fibers terminate.
Furthermore. i.1. PGE2 induces hyperalgesia and allodynia in conscious mice. All
these observations support the hypothesis that PGs are involved in C-fiber
mediated spinal sensitization processes underlying hyperalgesia and allodynia.
Tactile stimulation (A~-fiber input) induces prominent, well-defined allodynia after
i.t. bicuculline (BIC) in the rat. However, the mechanism of al10dynia is unclear.
The objective of the present study was to determine whether the low threshold
mechanoreceptive (A~) primary afferent fibers activate a similar prostanoid-
sensitizing mechanism in the rat spinal cord in allodynia. Male Sprague Dawley rats
(325-400g)were anaesthetized with halothane and maintained with urethane for the
continuous monitoring of blood pressure (MAP), heart rate (HR) and cortical
electroencephalogram (EEG). A laminectomy was performed to expose the dorsal
surface of the spinal cord. Unilateral application of bicuculline (0.1 I-Ig in 0.1 1-11) to
the L5 or L6 spinal segment induced a highly localized allodynia (e.g .• one or two
digits) on the ipsilateral hind paw. Thus, hair deflection (HD) (brushing the hair with
a cotton-tipped applicator) in the presence, but not absence of bicuculhne, evoked
an increase in MAP and HR, abrupt motor responses (MR) (e.g., withdrawal of the
hind leg, kicking, and/or scratching) on the affected side, and desynchrony of the
EEG. Bicuculline-allodynia was dose-dependent, yielding EDso values (95% CI) of
0.055 mg (0.035-0.085) for MAP; 0.075 mg (0.048-0.118) for HR and 0.097 mg
(0.078-0.122) for MR. Allodynia was sustained for up to 2 h with repeated
bicuculline doses without any detectable change in the location or area of peripheral
sensitization. Pretreatment with either the EP-receptor antagonist, SC-51322, the
cyclooxygenase (COX)-2 selective inhibitor, NS-398, or the NMDA-receptor
antagonist, AP-7, inhibited bicuculline-allodynia in a dose-dependent manner.
Innocuous tactile stimulation in the presence of i.t. PGE2 induced nociceptive,like
behavioural responses (allodynia) in conscious rats. These allodynic responses
were attenuated by SC-51322, or AP-7. Bicuculline, given i.t. 5 min before PGE2,
enhanced PGE2,induced anodynia and shifted the PGE2 dose-response curve to the
left. The spontaneous behavioural response after i.t. PGE2 was also enhanced by
bicuculline, but to a much less extent. The present results demonstrate: a) the utility
of topical drug delivery for inducing highly localized and sustained allodynia in the
lightly-anaesthetized rat; b) that PGs, synthesized by constitutive COX-2 in the
spinal cord in response to NMDA-dependent afferent input, contribute to the
abnormal processing of tactile input via spinal EP-receptors; c) i.t PGE2 induces
allodynia in conscious rats which is mediated by EP and NMDA receptors, and is
potentiated by pretreatment with i.1. bicuculline. These results suggest that low
threshold afferent input acquires access to a PG-sensitizing process during
bicuculline-disinhibition in the rat.
ACKNOWLEDGMENTS
I would like to express my sincere gratitude to my research supervisor, Dr.
Christopher W. Loomis, for his expertise and support during my degree program.
His guidance, keen insight and most importantly, his sense of humor, are greatly
appreciated.
I am also grateful to my co-supervisor Dr. Dellef Sieger, for his expert advice
and support, Dr. Carolyn Harley for her open door to me while serving on my thesis
committee and thought-provoking participation in my seminars.
I would also extend my gratitude to Mrs Janet Robinson, Ms Hemal
Khandwala fortheir skillful technical assistance and friendship. I would like to thank
Michael P. Hefferan, Darren D. 0' Rielly for the interesting discussion, benefICial
collaboration their friendship and company.
Iwould like to thank Mrs. Ferclos Guseilla and Denise, Heather, Margaret and
all the other staff of School of Pharmacy; their kind help and friendship made my life
here more enjoyable.
I am thankful to the School of Pharmacy, School of Graduate Studies, the
Pharmaceutical Manufacturer's Association Canada-Health Research Foundation
and the Medical Research Council of Canada for providing financial support during
my degree program.
TABLE OF CONTENTS
ABSTRACT...
ACKNOWLEDGMENTS..
TABLE OF CONTENTS...
LIST OF FIGURES .
LIST OF TABLES .
UST OF ABBREVIATIONS AND SYMBOLS...
. ii
. vi
. xi
. xvi
. xvii
. 1
. 10
. 1
. 3
. 6
1 INTRODUCTION...
1.1 Neuropathic Pain and Allodynia ...
1.2 Putative Mechanisms of Allodynia ...
1.3 Spinal Mechanisms of Allodynia ...
1.4 Evidence for Spinal Disinhibition After Neural Injury and
Experimental Models of Allodynia ...
1.5 Evidence for the Role of Prostaglandins in Normal Pain and
Hyperalgesia... ...............................13
Central NMDA Receptor Activation and the Effects of Spinal
Prostaglandins... . 17
Central Prostaglandins and Allodynia... . 21
1.6
1.7
1.8 Hypothesis and Specific objectives... . 23
2 METHODS...
2.1 Animals...
. 24
. 24
2.2 Anaesthetized Animal Experimentation 25
2.1.1 Laminectomy and Recording 25
2.2.2 General Protocol... 26
2.2.3 Drugs...
2.2.4 DataAnalysis...
2.3 Conscious Animal Experimentation...
2.3.1 Implantation of Intrathecal Catheter...
................................ 28
.. 29
. 30
. ...30
2.3.2 General Protocol... . 31
2.3.3 Behavioural Scoring System...
2.3.4 Drugs...
......................... 34
.. 35
2.3.5 Verification of Catheter Position 36
2.3.6 Data Analysis 36
3 RESULTS... .......37
3.1 Spinal Topical Bicuculline-Induced Allodynia in Anaesthetized Rats..37
3.1.1 Unilateral Application of Bicuculline to the Spinal Cord
Induces Localized Allodynia... ....37
3.1.2 Multiple Doses of Bicuculine Induce Sustained Altodynia .. .41
3.1.3 Distribution of Drug Solution After Topical Application
to the Spinal Cord 41
3.2 Inhibitory Effect of COX Inhibitor, NS-398 on Bicuculline-Allodynia...45
3.3 Inhibitory Effect of NMDA-Receptor Antagonist, AP-7 on Bicuculline-
~~~ia ~
vii
3.4 Inhibitory Effect of EP-Receptor Antagonist, SC-S1322 on Bicuculline·
Allodynia ... . 50
3.5 Intrathecal PGE, Elicits A1lodynia-Like Behaviour in Conscious Rats 55
3.5.1 Effects Observed in the Absence of Hair Deflection 55
3.5.2 Hair Deflection-Evoked AJlodynia 55
3.6 Effects of SC-51322 on Hair Deflection-Evoked AJlodynia in PGE,-
Trealed Rats... . 58
3.7 Effect of AP-7 on Hair Deflection-Evoked Allodynia in PGE,-Treated
Rats... . ......62
3.8 Effect of Bicuculline on Behavioural Responses in PGE2·Treated
Rats...
4 DISCUSSION...
.......67
. 69
4.1 Topical Application of Bicuculline to the Dorsal Spinal Cord Induces
localized AJlodynia... . 69
4.2 Effect of COX inhibitor NS·398 on Bicuculline·Atlodynia: Evidence of
PG Synthesis 74
4.3 Effect of AP·7 on Bicuculline·Allodynia: Role of NMDA Receptors 76
4.4 Effect of AP·7 on PGE,-Allodynia in Conscious Rats: Role of NMDA
Receptors... . 78
4.5 Effect of SC·51322 on Bicuculline- and PGE2·Allodynia: Role of EP
Receptors... .. 84
4.6 Bicuculline· and PGE2·Al1odynia 86
viii
4.7 Summary.....
5 REFERENCES...
. ...87
. 89
6 PUBLICATIONS ARISING FROM THIS WORK 114
Figure 1
Figure 2
LIST OF FIGURES
A schematic diagram showing the convergent input of primary
afferent fibers onto a wide dynamic range (WDR) neuron in the
spinal dorsal horn .. ......7
A schematic summary of the functional organization of elements
in the dorsal horn highlighting NMDA receptor activation and PG
release ... ....18
Figure 3 Protocol for the evaluation of behaviour in conscious PGEz treated
rats... ...........34
Figure 4 Representative tracings of hair deflection·evoked changes in
blood pressure, heart rate and EEG in a urethane-anaesthetized
rat... ..............................38-39
Figure 5 The dose·response relationship of topical bicuculline on hair
deflection·evoked changes in mean arterial pressure, heart rate
and motor responses... . 42
Figure 6 The maximum hair deflection·evoked change in mean arterial
pressure, heart rate and molar response after repeated doses of
bicuculline (0.1 ).1g)... .... .44
Figure 7 Fluorescent photomicrograph showing transverse sections of the left
and right lumbar dorsal horn... . 46
Figure a The time-course of NS-398 on the maximum hair deflection·evoked
change in mean arterial pressure, heart rate and motor responses in
bicuculline-trealed rats... . 47
Figure 9 The dose-response relationship of NS·39a on hair deflection-evoked
allodynia in bicucul1ine trealed rats... . .48
Figure 10 The dose-response relationship of AP-7 on hair deflection-evoked
al10dynia in bicuculline-treated rats ... . 51
Figure 11 The time-course of Ap·7 on the maximum hair deflection-evoked
change in mean arterial blood pressure, heart rate and motor
responses in bicuculline-treated rats... .. .....52
Fi9ure 12 The time-course of SC-51322 on the maximum hair deflection-evoked
change in mean arterial pressure, heart rate and molar responses in
bicuculline-treated rats ... . 53
Figure 13 The dose-response relationship of SC-51322 on hair deflection-
evoked allodynia in bicuculline-treated rats... . . .....54
xi
Figure 14 The time-course of behavioural responses without hair deflection in
intrathecal PGE2-treated rats... . 56
Figure 15 The dose-response relationship of intrathecal PGE2; behavioural
responses without hair deflection..... . 57
Figure 16 The time-course of hair deflection-evoked behavioural responses in
intrathecal PGE2-treated rats... . 59
Figure 17 The dose-response relationship of intrathecal PGE2 : hair deflection-
evoked allodynia.... .. 60
Figure 18 The lime-course of SC-51322 (100 ~g) in PGE2-treated rats ........61
Figure 19 The dose-response relationship of SC-51322 on hair deflection-
evoked allodynia in PGE2-trealed rats... . 63
Figure 20 The dose-response relationship of SC-51322 without hair deflection
in PGE2-treated rats... . 64
Figure 21 The time-course of Ap-7 in PGE2·treated rats 65
xii
Figure 22 The effect of AP-7 of behaviour with and without hair deflection in
PGE1-treated rats... . 66
Figure 23 The time-course of intrathecal bicuculline in PGE1-treated rats.....68
Figure 24 The effect of intrathecal bicuculline on hair deflection-evoked
allodynia in PGE1-trealed rats... . 70
Figure 25 The effect of intrathecal bicuculline on PGE2-induced behaviour
without hair deflection... . 71
xiii
Table 1
Table 2
Table 3
LIST OF TABLES
Comparison of topical and Lt. BIC induced anodynia in the rat. .. ..40
EOSQ'S and 95% confidence intervals (CI) of bieueulline applied
topically to the dorsal surface of the spinal cord ..43
Summary of the 10$(/'5 and 95% confidence intervals (CI) of NS-398,
AP-7 and SC-51322 in bicuculline-treated rats 49
LIST OF ABBREVIATIONS AND SYMBOLS
07:00h 7 o'clock in the moming
%
"m
A-fiber
ANOVA
AP-7
BIC
bpm
BP
C-fiber
Ca'·
CGRP
CI
CNS
Co.
COX
CSF
DMSQ
EAA
ED~
EEG
pluS and minus, in addition to, subtracted from (about the
mean)
percent
greater than
less than
degrees Celsius
microgram, 10~ grams, unit of mass
microliter, 10~ liters, unit of volume
micrometer, 10./1 meters, unit of length
a class of primary afferent neurons
analysis of variance
(±)-2-amino-7-phosphonoheptanoic acid
(-) bicuculline [(-)bicuculline methiodide]
beats per minute
blood pressure
a class of primary afferent neurons
calcium ion
calcitonin gene-related peptide
confidence interval
central neNOUS system
company
cyclooxygenase
cerebrospinal fluid
dimethyl sulfoxide. an organic solvent
excitatory amino acid
effective dose for 50 percent response
electroencephatogram(s)igraph{s)
9
GASA
Glu
Gs
GI
HO
H9
HR
IASP
IO~
i.e.
i.p.
i.t.
i.v.
L5
L6
LI
MAP
MK-801
min
MR
mRNA
NMDA
NS-398
PE-10
PG
S
gram(s)
y-aminobutyric acid, y-aminobulyrate
glutamate
stimulatory G-protein
inhibitory G-protein
haur{s)
hair deflection
elemental symbol for mercury
heart rate
International Association for the Study of Pain
inhibitory dose decreasing a response by 50 percent
id est (that is)
intraperitoneal(ly)
intrathecal
intravenous(ly)
lumbar vertebra number 5
lumbar vertebra number 6
-like immunoreactivity
mean arterial pressure
dizocilpine maleate
minule(s)
motor response or molor response duration
messenger ribonucleic acid
number of determinations
N-methyl-O-aspartic acid
N-(2-cyclohexyloxy-4-nitrophenyl)- methanesulfonamide
size 10 polyethylene tUbing (diameter-0.61 mm)
prostaglandin
second(s)
subcutaneous{ly)
xvi
SC·51322
SO
SEM
SP
STR
T
WOR
[8-dllorodibenz(b,f)(1,4)oxazepine-10(11 Hl-carboxyl acid, 2-{3-
{2-[fury-anylmethyfJthio)-1-<lxopropyl)hyrazide
standard deviation
standard error of the mean
substance P, a neurotransmitter
strychnine
time
wide dynamic range
xvii
1 INTRODUCTION
1.1 Neuropathic Pain and AlJodynia
Neuropathic pain is defined by the International Association for the Study of
Pain (IASP) as ·pain initiated or caused by a primary lesion or dysfunction in the
nervous system- (Merskey, 1994). It usually arises from trauma or disease in the
peripheral nerves, the posterior spinal roots, the spinal cord itself, or certain regions
of the brain. Examples include phantom limb pain; central post-stroke pain;
diabetic, alcoholic, nutritional, traumatic or cancerous neuropathy; anterior spinal
artery syndrome; postherpetic neural9ia; reflex sympathetic dystrophy; plexus
avulsion; postcordotomy dysesthesia and painful conditions associated with
paraplegia and multiple sclerosis (Shibasaki and Kuroiwa, 1974; Boivie, 1989;
Tasker, 1990; Portenoy and Hagen, 1990; Tanelian and Brose, 1991; Price et aI.,
1992; Triggs and Beric, 1992; Baron and Saguer, 1993; Portenoy, 2000).
The rate of occurrence of neuropathic pain varies with the causative event.
For example, poststroke pain was found in 16 out of 207 (8%) stroke patients
(Andersen et al., 1995). Postherpetic neuralgia (PHN), defined as neuropathic pain
persisting for 1 month or longer after herpes zoster infection, affects about 10% of
all patients who have contracted the disease (Watson, 1995). This increases to
approximately 50% of patients infected with herpes zoster who are older than 50
years (Beydoun et al., 1999).
Spinal cord injury, which affects about one in 40 patients who present 10 a
major trauma centre (Kearney el aI., 1991), is another common cause of
neuropathic pain. Although the annual incidence in developed countries is relatively
-1-
low (from 11.5-53.4 per million population) (Botterell et al.. 1975; Kurtzke 1975).
victims frequently develop chronic musculooskeletal and neuropathic pain. in
addition to the loss of motor control. Approximately 30% of patients with spinal cord
injury experience symptoms of neuropathic pain. This neuropathic pain is a
relatively rare and idiosyncratic outcome of nerve injury (Noordenbos and Wall,
1981; Amer and Meyerson, 1988; Tasker, 1990). However, it is extremely
debilitating, often intractable and a major burden on the health and social systems
(Arner and Meyerson, 1988; Rowbotham et at, 1991; Baron and Saguer, 1993:
Schmader, 1998).
Neuropathic pain differs from normal nociceptive pain in a number of
important ways. The former is chronic in nature, persisting for years or even
decades after the initial injury has healed. The onset of neuropathic pain is
normally delayed for weeks to months after the causative event (Tasker, 1990). For
example, 82% of patients with spinal rord lesions experienced a delay in the onset
of pain, which ranged from less than a month to more than one year after injury
(Tasker et aI., 1992). Neuropathic pain is frequently described by patients as a
burning, ripping, tearing, pressing or twisting pain, terms normally associated with
physical injury. Patients are often unable to identify or locate the inciting stimulus
and radiation of sensation, abnormal temporal summation, and after-sensations are
frequent sequelae oflhis syndrome (Lindblom and Varrillo, 1979: Noordenbos and
Wall, 1981; Price at at, 1992).
One of the major problems of neuropathic pain is its poor response to
treatment. Surgical interventions, intended to alleviate neuropathic pain, usually
-2-
provide only incomplete and temporary relief, with the pain eventually returning
(Tasker et aI., 1992; Eide, 1998). Pharmacotherapy with dl1Jgs such as opioid
analgesics, tricyclic antidepressants, anticonvulsants, barbiturates, local anesthetics
and/or use-dependent sodium channel blockers is highly variable from patient to
patient, and rarely successful in effecting complete pain control. As a result, the
majority of patients with neuropathic pain are inadequately controlled, making
neuropathic pain a serious clinical problem and a major therapeutic challenge (Eide,
1998).
Surveys of patients with neuropathic pain report that the most common and
troublesome symptom is allodynia (Campbell et aI., 1988; Raja et aI., 1988).
Allodynia is defined by the IASP as ~pain arising from a stimulus that does not
normally evoke pain" (Merskey. 1986). Thus, a cold draft of air or the light touch of
clothing can acquire the ability to evoke excl1Jciating pain after nerve injury.
Mechanical (tactile)allodynia is the most common type, occurring in 54% of patients
with central neuropathic pain and 48% of patients with peripheral neuropathic pain
(Nurmikko and Hietaharju, 1992), and it is the major clinical form of allodynia (Woolf
and Doubell, 1994; Ma and Woolf, 1996).
1.2 Putative Mechanisms of ANodynia
A fundamental characteristic of allodynia is the altered afferent input (Af3- vs
C-fibers) that elicits pain. Thus, ischemic nerve block or nerve compression
eliminated allodynia and the sensation of light touch on adjacent normal skin in
patients with neuropathic pain (Campbell et aI., 1988; Price et at, 1989). These
-3-
results indicated that both sensations are mediated by the same neural elements,
namely All fibers. In contrast, temperature discrimination in the same region was
unaffected, indicating that functional A& and C-fibers do not mediate the allodynia
(Campbell et al., 1988). Studies of the response latencies for the detection of
mechanical stimuli showed that the conduction velocity for detection of pain in the
nerve-injured limb was similar to that for detection of touch in the normal limb
(Lindblom and Verrillo, 1979; Campbell et aI., 1988; Gracely et aI., 1992).
Additional evidence for the involvement of All-fibers in allodynia is derived from the
observation that high-frequency, low-intensity electrical nerve stimulation
exacerbates allodynia. rather than eliciting the analgesic effect seen with
nociceptive pain (Price et aI., 1992). Since All-fibers do not normally cause pain,
their acqUired ability to do so after peripheral or central nerve injury implies a
dramatic change in somatosensory processing at the spinal and/or supraspinal
level.
In the periphery, nerve injury has been shown to result in a variety of
changes. These include: i) spontaneous afferent activity in the injured terminals
andlor the dorsal root ganglion cells of the injured axons (Devor 1991); ii) increased
mechanosensitivity of the neuroma leading to increased A~-fiber discharges
(Babbedge et al; 1996); iii) infiltration of inflammatory cells such as macrophages
into the myelin lamellae similar to that seen in inflammatory neuropathies (Nukada
et aI., 2000); iv) development of post-ganglionic sympathetic sprouts around type
A dorsal root ganglion cells (McLachlan et at, 1993); and v) ephaptic connections
(abnormal electrical connections between demyelinated adjacent axons, (Janig et
-4-
ai"1988). Each of these has the ability to generate an excitatory barrage reaching
the spinal cord. Sustained excitatory input is known to induce a facilitated central
hyperexcitability in the spinal cord (Coderre, 1993; Millan, 1999).
Nerve injury is also known to elicit pronounced changes in the spinal cord.
These include: i) the sprouting of nerve terminals of large primary afferent (A~)
fibers into lamina I and II of the dorsal hom of spinal cord (LaMotte et al., 1991;
Woolf et aI., 1992); ii) changes in the postsynaptic function of spinal neurons
including the loss of opioid binding sites in the superiicial dorsal hom (Besse el aI.,
1992; Molander et aI., 1992); iii) the appearance of new neurotransmitters such as
neuropeptide Y, galanin. and vasoactive intestinal peptide in spinal afferent
terminals (Wakisaka et aI., 1992); iv) alterations in intracellular and cell suriace
markers (e.g., glial fibrillary acidic protein) (Garrison at al,. 191992); v) the
upregulation of several immediate early gene products in the spinal cord such as
c-fos and c-jun which are implicated in the increased responsiveness of second-
order neurons (Herdegen et a!.. 91. Cameron-Curry et at, 1991); and Vi) the
appearance of dark staining neurons in the dorsal hom thought to be deteriorating
interneurons (Sugimoto et aI., 1989; 1990; Mayer et at, 1999).
These presynaptic and postsynaptic changes suggest a major reorganization
of spinal cord connections andfor nerve function after nerve injury. Many of these
are directly or indirectly correlated with the development of hypersensitivity in the
spinal cord (Millan, 1999). Although the functional significance of these changes
remains to be determined, it is clear that the spinal cord is a major site of injury-
induced adaptations to neuropathic pain.
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1.3 Spinal Mechanisms of AlJodynia
The spinal cord contains the first synaptic connection in somatosensory
pathways, and represents the first site of signal processing. Thus, primalY afferent
fibers form extensive synaptic contacts with second order neurons in the dorsal
hom. The latter are either relay cells, with axons projecting to the brain stem or
thalamus, or intemeurons that transfer information locally to other intemeurons or
to relay cells in adjacent spinal segments. Functionally, second order neurons are
classified into three general types (Besson and Chaouch, 1987; HenlY, 1989): 1)
non-nociceptive (those receiving input from Ab primalY afferent fibers), 2)
nociceptive specific (those receiving input from C and Ad fibers), and 3) nociceptive
non-specific or wide dynamic range (WDR) neurons. The latter group, which are
known to be involved in normal pain processing, receive convergent input from both
nociceptive and non-nociceptive primalY afferent fibers (Figure 1A). This synaptic
arrangement and the ability of these neurons to elicit a graded response to a range
of stimulus intensities make WDR neurons a logical site for the investigation of
allodynia. A basic question related to WDR neurons and allodynia is why, under
normal conditions, All input is not routinely perceived as pain.
The ultimate perception of a stimulus as tactile or nociceptive appears to be
governed by the balance of excitatolY and inhibilolY input that determines the
discharge of second order neurons (see reviews by Yaksh et aI., 1999b; Milan,
1999; Figure 1A, B). Convergent lines of evidence suggest that low threshold All
afferent fibers activate inhibitolY interneurons in the spinal dorsal horn which
modulate the evoked discharge ofWDR neurons (Millan, 1999) (Figure 1A). These
lUI lU~
--"""~?
Tobroln
Figure 1. A schematic diagram showing the convergent input of primary
afferent fibers onto a wide dynamic range (WOR) neuron In the spinal dorsal
hom. A: In nonnal conditions. WDR neurons receive input from large
diameter, myelinated, low·threshold mechanoreceptive (lTM) AI3 fibers;
intermediate diameter, myelinated. high threshold mechanoreceptive (HTM)
and thermosensitive (heat) AfJ fibers, and small diameter, unmyelinated,
polymodal C fibers. Collateral axons of LTM fibers make synaptic contacts
with small inhibitory intemeurons (small filled circle and arrow) that modulate
the response of WDR neurons to LTM input. B: Central or peripheral nerve
injury may induce dysfunction and/orloss of these lntemeurons. The removal
of this inhibitory modulation results in an exaggerated response to normal
low threshold mechanoreceptive (A~) input that could be mistakenly
interpreted as pain. The small open circle and arrow represents an excitatory
Interneuron. The shaded circle and arrow represents damaged inhibitory
interneuron. The + and • symbols indicate excitation and inhibition,
respectively (adapted from Wall et aI., 1989).
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inhibitory intemeurons contain GABA and glycine (Todd and Sullivan; 1990: Carlton
et at. 1996). GABA-like immunoreactivity (1I) is concentrated in the somata,
dendrites and axon terminals within laminae 1·111 of the spinal dorsal hom (Todd,
1990). In the spinal cord, GABAergic dendrites receive synaptic input from the
central terminals of primary afferent fibers, especially those of the low·thrashold,
myelinated, A13·type (Todd, 1990; Todd at al., 1996). In tum, GABA·containing
neurons synapse directly on the proximal dendrites or cell bodies of spinothalamic
tract (STI) cells (Carlton and Hayes; 1990; Carlton et aI., 1992) which relay
information to sensory nuclei in the thalamus.
Immunohistochemical studies have also confirmed the presence of GABAA
receptors in the synaptic regions formed by these inlerneurons (Solodkin et aI.,
1984). Indeed, GABA interneurons are thought to effect both presynaptic inhibition
at axoaxonic synapses (Solodkin et aI., 1984), and postsynaptic inhibition at
axodendrilic and axosomalic synapses by means of the GABAA receptors present
at these sites (Todd et aI., 1996).
Likewise, glycinergic cells are most abundant in lamina III and IV of the spinal
dorsal hom (less in lamina II, and V) (Carlton et at, 1996) where glycine appears
to co--exist with GABA in many (but not all) GABAergic cells (Todd, 1990). The
dendrites of neurons exhibitingglycine·U in laminae II and III are postsynaptic to the
central axons of type II (myelinated axons), but not type I (unmyelinated axons)
glomeruli (Todd, 1990). Thus, glycinergic interneurons appear to receive a major
monosynaptic input from myelinated primary afferent fibers (Todd 1990; Carlton et
al., 1996). Glycinergic interneurons also make functional synaptic contacts with
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STT cells in the spinal dorsal horn (Hori and Endo, 1992; Antal et aI., 1996).
Consistent with these data are reports of glycine receptor- and GABAA receptor-L1
in the synapses formed by these interneurons. Glycine and GABAA receptor
immunoreactivity was enriched in the postsynaptic dendrites, cell bodies as well as
presynaptic axons. These results suggest that glycine effects both pre-synaptic and
post-synaptic inhibition of second order neurons in cats and rats (Solodkin et aI.,
1984; Todd et aI., 1996) and provide further anatomical evidence for the model
illustrated in Figure 1A.
Glycine and GABA are known to exert powerful inhibitory effects on spinal
neurons. For example, in cats and monkeys, iontophoretic delivery of GABA or
glycine onto STT cells elicited a profound and dose-related inhibition of their
responses to cutaneous mechanical stimuli (Lin, 1996a; 1996b; Sorkin and Puig,
1996; Sorkin et at, 1998). Likewise, iontophoresis of glycine or GABA in the cat
dorsal horn diminished the responsiveness of spinal neurons to light tactile
stimulation (light touch/light pressure), and decreased the size of the cutaneous
receptive fields (Zieglgansberger and Herz, 1971). Conversely, application of the
GABAA receptor antagonist, bicuculline, or the glycine receptor antagonist,
strychnine into the dorsal horn increased both the background activity and the
responses to cutaneous mechanical stimuli (Un et aI., 1996; Sorkin et aI., 1998;
Willcockson et aI., 1984). These data suggest a tonic inhibition of STT cells by
GABAergic and glycinergic neurons. The intrathecal (i.t.) injection of bicuculline and
strychnine has also been shown to induce a long-lasting increase in the
responsiveness of dorsal hom neurons to low intensity, AI3-fiber stimulation
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resembling the hyperexcitability of allodynia (Sivilotti and Doubell, 1994). Finally,
genetic variants such as the Poll Hereford calf (Gundlach et aI., 1988) and the
spastic mouse (White and Heller, 1982), which exhibit up to 10-fold decrease in
STR binding in the spinal cord, display exaggerated sensitivity to even modest
cutaneous stimulation.
Collectively, these studies provide convergent evidence thai low threshold
AfHibers activate local GABAergic and glycinergic interneurons that regulate the
excitability ofWDR neurons (Carlton et aI., 1996; Millan, 1999), and support for the
modulatory effects of GABA and glycine in spinal sensory processing. Thus, the
encoding of a low-threshold mechanical stimulus as an innocuous event may
depend on the presence of intrinsic GABAergic and/or glycinergic inhibition in the
spinal dorsal horn
1.4 Evidence for Spinal Disinhibition After Neural Injury and Experimental Models
of Allodynia
By virtue of its location and anatomy, the spinal cord is vulnerable to injuries
that commonly precede the onset of clinical allodynia (Tasker, 1990). For example,
infarction of the anterior spinal artery (anterior spinal arlery syndrome) leads to
painful burning dysesthesia below the level of lhe spinal lesion which is refractory
to opioid, anticonvulsant and antidepressant therapy (Triggs and Beric, 1992).
Traumatic spinal cord injury is also a common cause of neuropathic pain. This is
generally characterized by diffuse burning dysesthetic sensations (inclUding
allodynia) distal to the level of spinal injury (Davidoff et aI., 1987; Yezierski, 1996).
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That the spinal cord is a major site of dysfunction in neuropathic pain is not
surprising given the fact that the dorsal hom contains the first synapse in pathways
sUbserving nociceptioo.
Animals subjected to central or peripheral nerve injury exhibit a reduction in
the functional tone ofspinal GABAergic and glycinergic intemeurons. For example,
photochemically-induced spinal cord ischemia in the rat produced severe
mechanical allodynia, and a significant decrease in GABA-L1 in lamina I-III of the
irradiated dorsal hom (Demediuk et al., 1989; Hao el al., 1991; Zhang et al., 1994).
Electrophysiological studies revealed enhanced sensitivity of spinal WDR neurons
to electrical, and low threshold mechanical stimulation that persisted 10-20 days
after focal spinal ischemia corresponding to the behavioural data (Hao et aI.,
1992a). This sensory dysfunction was limited to All afferent fiber input (Hao et aI.,
1992a, b); the responses to A6IC fiber activity remained normal. Of relevance to the
spinal disinhibition model of a1lodynia is the observation that the recovery from
a1lodynia paral1elled the return of GABAergic tone in the spinal dorsal hom (Zhan9
et aI., 1994).
Similar observations have been reported following partial ligation of the
sciatic nerve; an experimental model of peripheral neuropathy. Thus, GABA-L1 was
si9nificantly decreased on the side ipsilateral to the sciatic nerve ligation (Ibuki et
al., 1997; Eaton et al., 1999). Abnormal pain-related behaviour, including cold and
tactile allodynia and thermal and tactile hyperalgesia, parallelled these
immunohistochemical changes in the spinal dorsal hom. Extracellular recordin9s
of WDR neurons revealed a significant increase in the frequency of spontaneous
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discharges, and the responsiveness to brush and light pressure (Yakhnitsa et aI.,
1999). Interestingly, spinal cord stimulation (SCS) depressed the activity of WDR
neurons, and produced a marked and long-lasting increase in the threshold of
activation by tactile input (Meyerson et at, 1995; Yakhnitsa et aI., 1999). These
inhibitory effects were associated with a significant increase of GABA concentration
in spinal microdialysate samples (Linderoth et al., 1994; Stiller et at, 1996). These
results provide further evidence for the role of GABAergic modulation of the low
threshold (A-fiber) mediated WDR neuron hyperactivity in peripheral neuropathy.
In tum, pharmacological blockade of spinal GABAergic and glycinergic tone
with bicuculline and strychnine enhanced the already established hyperalgesia and
allodynia following sciatic nerve ligation (Yamamoto and Yaksh, 1993; Satoh and
Ornate, 1996; Hwang and Yaksh, 1997). Conversely, tactile and cold allodynia and
hyperalgesia were completely blocked by a single dose of i.t. GABA, and
significantly reduced by cultured GABAergic cells grafted into the subarachnoid
space close to the spinal dorsal horn (Eaton et aI., 1999). These results suggest
that a local supply of GABA in the spinal dorsal horn was able to reverse the
development of allodynia following peripheral nerve injury. Finally, a bilateral
reduction in the population of STR-sensitive glycine receptors in the spinal dorsal
horn has been reported after unilateral constriction of the rat sciatic nerve (Simpson
and Hwang, 1998).
Even in the absence of nerve injury, a reduction in spinal GABAergic and/or
glycinergic tone evokes robust allodynia in experimental animals. Cumulative
evidence indicates that normally innocuous mechanical stimulation acquires
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nociceptive characteristics during the pharmacological blockade ofspinal glycine or
GABA" receptors (Yaksh, 1989; Shennan and Loomis, 1994). Thus, the i.t.
injection of sub-convulsive doses of strychnine or bicuculline induced an
exaggerated excitatory state in spinal cord Whereby innocuous tactile stimulation
evoked behavioral, autonomic and neurochemical responses characteristic of a
noxiousevent(Beyeretal., 1985;Yaksh, 1989: Sherman and Loomis, 1994: 1995).
The resulting allodynia was: 1) evoked by low threshold All-fiber activity; 2) only
elicited by li9ht brushing of the hair at circumscribed sites corresponding to the
spinal segments affected by Lt. strychnine or bicuculline (segmentally organized;
Sherman and Loomis 1994); 3) reversible and reproducible; 4) unaffected by
phannacological treatments that interfere with high-threshold C·fiber input (e.g.,
morphine, capsaicin, substance P antagonists) (Triggs and Beric, 1992); and 5)
attenuated by i.t. glycine, the glycine pro-drug, milacemide or the GABA" agonist,
muscimol (Hwang and Yaksh, 1997: Khandwala and Loomis, 1998).
In summary, there is growing evidence that disruption of GABAergic and/or
gtycinergic modulation in the spinal dorsal hom, either pharmacologically or by
nerve injury, yields an exaggerated sensitivity to otherwise innocuous stimuli (Figure
1A, B). In the absence of this inhibitory modulation, A13·fibers appear to activate
cellular mechanisms normally limited to nociceptive signalling; and only recruited by
repealed, high-threshold C-fiber input.
1.5 Evidence for the Role of Prostaglandins in Normal Pain and Hyperalgesia
One of the notable biochemical mechanisms enhancing pain signalling in the
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spinal cord is the production of prostaglandins (PGs). This mechanism is
completely independent of the well-known roJe of peripheral PGs in pain and
inflammation. That PGs might be generated within the central nervous system
(CNS) in response to repeated C·fiber input was first suggested by Malmberg and
Yaksh (1992a). This was based on the observation that non-steroidal anti-
inflammatory drugs (NSAIDs), injected directly into spinal subarachnoid space of
conscious rats, elicited dose-dependent inhibition of the behavioral responses
evoked by formalin injection into the foot pad (Malmberg and Yaksh, 1992a).
NSAIDs, given spinally, were 100-1000 times more potent than systemic
administration in inhibiting the second phase of the formalin test (Malmberg and
Yaksh, 1992a). Intrathecal NSAIDs were also effective in inhibiting glutamate- or
substance P-induced hyperalgesia in the rat (Malmberg and Yaksh. 1992b). These
results implicate a spinal antinociceptive effect of NSAIDs that is distinct from their
usual anti-inflammatory actions, and are consistent with a central as well as
peripheral site of action in pain. The spinal antinociceptive effect of NSAIDs was
found to be stereospecifIC (Jett et at. 1999). suggesting that the inhibition of
c:ycIooxygenase in the spinal cord, and thus the suppression of central PG
synthesis, is the mechanism responsible.
The central production of PGs in response to high-threshold nociceptive input
has been confirmed in in vivo and in vitro experiments. The injection of
carrageenan/kaolin into the knee joint of the rat evoked persistent pain behaviour
and a time-dependent increase in the concentration of PGE2 in spinal microdialysis
samples (146 t 11% and 143 ± 18% of baseline 10 min and 24 h after knee joint
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carrageenanlkaolin injection, respectively) (Yang et at. 1996). An increase in PGE2
concentration of 109:t 10% and 83:t 15% of baseline was also re~>rted during the
first and second phase of the rat fonnalin test, respectively (Malmberg and Yaksh,
1995b.c). Whereas both pain behaviour and the increase in PGE2 concentration
were suppressed by i.t. S (+)-ibuprofen, the R(-)-enanliomer had no effect
(Malmberg and Yaksh, 1995c; Yang etal.. 1996). The i.t. injection of substance P,
which induces hyperalgesia in the rat, also elicited a dramatic increase (362 ± 37%
of baseline) in PGE2 concentration in spinal CSF (Hua et at. 1999).
The ability of the spinal cord to generate PGs has been verified using an in
vitro spinal superfusion model (Dirig and Yaksh, 1999). Spinal cords, harvested
from rats that were pretreated with kaolin/carrageenan into knee joint for 5-72 h,
exhibited an increased release of PGE2 into the perfusion medium compared to
control. Further elevations in PGE2 concentrations were evoked by perfusion of
these same spinal cords with substance P (0.1-1.0 flM) or capsaicin (0.1·10 flM).
Thus. PGE2 synthesis in the spinal cord is triggered by peripheral inflammation and
by direct exposure to receptor ligands known to induce hyperalgesia in response to
peripheral input.
The concept that PGs are generated centrally has been strengthened by
reports that cydooxygenase (COX), the prostanoid·fonning enzyme, is constitutively
present in the brain and spinal cord. Immunocytochemical and autoradiographic
studies of the CNS have verified the presence of COX-L1 in nociceptive pathways
in the spinal cord (Goppett-Struebe and Beiche, 1997: Willingale et al.. 1997:
Beiche et al.. 1998a,b). This immunoreactivity was especially abundant in the
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superficial dorsal horn where the nociceptive primary afferent fibers are known to
terminate. COX-2-1I (one of the two isoforms of COX) was found in neurons of
laminae II-III, motorneurons of lamina IX and in glial cells located in the spinal cord
of untreated rats (Goppelt-Struebe and Seiche. 1997).
Cyclooxygenase in the spinal cord is also subject to induction. A transient
increase (2-fold) in COX-2 mRNA, and a smaller increase in COX-2 protein. were
detected bilaterally in the lumbar spinal cord of the rat following acute carrageenan-
induced, peripheral inflammation (Goppelt-Struebe and Seiche. 1997; Ichitani etai.,
1997; Hay et al.. 1997). Western blot analysis revealed a 1.6·fold increase in the
level of COX·2 protein in the lumbar dorsal hom (lamina II-III) 22 days after the
onset of adjuvant-induced arthritis in the rat (Goppelt-Struebe and Seiche, 1997;
Seiche et al.. 1998a,b). These results indicate that the COX-2 is also inducible in
the CNS, and may be responsible for the increase in spinal prostanoid synthesis
and release during peripheral inflammation.
The localization of COX in the dendrites of central excitatory neurons in the
spinal cord supports a role for PGs in the modulation of synaptic signalling
(Yamamoto and Yaksh, 1993). This hypothesis is supported by the abundance of
PGE2 binding sites in the spinal dorsal hom (Onoe et aI., 1992; Matsumura et ai..
1992: 1995). These appear to be located on the terminals of primary afferent fibers,
since these binding sites almost completely disappeared after dorsal rhizotomy.
Their density on the operated side was only 4 ± 4% of the control side, 8 days after
surgery (Matsumura et aI., 1995). This pattern of PGE2 receptor binding is
consistent with a presynaptic facilitation of nociceptive signalling.
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In summary, there is considerable evidence that PGs are synthesized and
released in the spinal cord in response 10 nociceptive (C-fiber) input. The temporal
correlation of this central biochemical process with pain behaviour and peripheral
inflammation indicates that spinal PGs may be critical in the induction of a central
pain state at the spinal level.
1.6 Central NMDA Receptor Activation and the Effects of Spinal Prostaglandins
Persistent C-fiber input from peripheral inflammation or repeated high-
threshold electrical stimulation effects a rapid change in the sensitivity of spinal
dorsal hom neurons. This process, known as wind-up, reflects the slow temporal
summation of C-afferent fiber-evoked responses and is thought to be an important
central mechanism of hyperalgesia (Mayer, et aI., 1999). This process is triggered
by the co-release of glutamate and substance P from the terminals of primary
afferent C-fibers. Acting at NMDA· and NK1-receptorson the membranes of dorsal
horn neurons (Wall and Woolf, 1986; Dickenson et aI., 1997; Yaksh et a!., 1999b),
these neurotransmitters elicit prolonged depolarizations. Pharmacological studies
have consistently identified the NMDA receptor as an essential feature in the
development of wind-up (see Figure 2) (Dickenson and Sullivan, 1990; Yaksh et aI.,
1999b). Indeed, all aspects of the hyperalgesic state, regardless of the initiating
event, are reversed by agents that block spinal NMDA receptors (Chaplan et a!.,
1997; Yaksh, 1999a).
The NMOA receptor normally remains inactive. even in the presence of
released glutamate, because it is partially blocked by MgH • Prolonged depolariza-
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Fig. 2 A schematic summary of the functional organization of elements in
dorsal horn showing the NMOA receptor activation and PG release. The
primary afferent C-fibers contain and release both peptide and excitatory
amino acid products. Primary A~fibers contain and release excitatory amino
acids. It is believed that glutamate activates the second order neurons via
non-NMOA receptors on sites postsynaptic to A or C afferent input. Excitatory
interneurons, excited by an appropriate afferent barrage, activate second
order neurons via NMOA receptors. This leads to an increase In intracellular
Ca'" and the activation of a number of enzymes (e.g., COX, NOS) (see text for
details). Inhibitory Interneurons, activated by A fibers (not shown in the
graph), release GABA or glycine and modulate the excitability of second order
neurons. Abbreviations: AA: arachidonic acid, COX: cyclooxygenase, ORG:
dorsal root ganglion, Glu: glutamate, non·NMOA: non-N-methyl-O-aspartic
acid receptor, NK-1: neurokinin-1 receptor, NO: nitric oxide, NOS: NO
synthase, NMOA:,NMOAreceptor, PG: prostaglandin, PLA.,: phospholipase~,
sP: substance P, WOR: wide dynamic range (Adapted from Yaksh et al.
1999b).
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tion evoked by substance P is thought to remove the voltage-dependent MgH block
of the NMDA receptor. This allows glutamate to exert its agonist effect at the NMDA
receptor-ehannel complex. The opening of this channel leads to a large influx of
CaH into the cytosol and the initiation of a cascade of intracellular events
(MacDermott et al., 1986; Chaplan et aI., 1994) induding: 1) the
translocation/activation of protein kinases such as protein kinase C (Sluka and
Willis, 1997; Ramakers, et al., 1997; Millan, 1999); 2) the release of arachidonic
acid from the cell membrane into the cytosol; 3) the activation of COX and nitric
oxide synthase (NOS); and 4) the generation of prostanoids and NO within the cell.
The latter are thought to diffuse from the perikarya to adjacent cells where they
promote excitatory neurotransmitter release from primary and non-primary afferent
terminals (Yaksh, 1999a; Yaksh et aI., 1999b; Milan, 1999) (Figure 2).
The exact mechanisms by which central PGs enhance nociceptive signalling
have yet to be elucidated. One strong possibility is that PGs exert their effects
through excitatory receptors located on primary afferent terminals that form synaptic
connections with second order neurons and/or excitatory intemeurons in the dorsal
hom (Millan, 1999). In this regard, PGE2 has been shown to evoke Ca H -dependent
release of glutamate from synaptosomes of rat spinal cord (maximum effect at 1
nM) (Nishihara et al., 1995), and substance P from cultured rat dorsal root ganglion
(DRG) cells (Vasko et aI., 1994) or spinal cord slices (Vasko, 1995). The effect of
PGE2 (100nM) on substance P release was inhibited by the selective EPj-receptor
antagonist, SC19220, and by guanosine-5'-[beta-thio] diphosphate, an inhibitor of
stimulatory G-protein (Gs) to which the EP1 receptor is coupled (Cui and Nicol.
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1995; White, 1996), Conversely, guanosine-5'-[gamma·thio] triphosphate, an
activator of Gs protein, enhanced PGE2-evoked release of substance P. Perfusion
with low concentrations of PGE2 has also been shown to facilitate capsaicin- or
bradykinin-evoked release of substance P or CGRP from rat spinal cord slices
(Hingtgen et aI., 1995; Vasko, 1995). Collectively, these results indicate that PGE2,
acting through G-protein-coupled receptors, can directly effect neurotransmitter
release from the spinal cord, as well as augment the release of neuropeptides from
the spinal terminals of C-fibers evoked by known algogenic agents.
PGs may also enhance the excitability of dorsal hom neurons to afferent
input by a direct postsynaptic effect. In an early study, microiontophoretic
application of PGE 1 to motorneurons and interneurons in the isolated spinal cord of
the frog induced an abrupt excitatory effect (Coceani and Viti, 1975). More recently,
PGE2 was shown to induce a long-lasting facilitation of evoked excitatory
postsynaptic currents of dorsal hom neurons in mice (Minami et al., 1999). The
"wind-up· of a spinal C·fiber nociceptive reflex, induced by repeated electrical
stimulation of the sural nerve, was also dose-dependently inhibited by the 1.1. or i.v.
administration of indomethacin, and by i.v. administration of the selective COX-2
inhibitor, SC58125 (Bustamante et aI., 1997; Willingale et aI., 1997). While these
studies do not preclude a change in neuronal excitability secondary to an increase
in glutamate and neuropeptide release, they do provide further support for the
positive modulatory effect of PGs on spinal neurotransmission.
In summary, there is substantial evidence that: 1) PGs are synthesized in
and released from the spinal cord in response 10 noxious (high-threshold) C-fiber
-20-
input; 2) central PG synthesis is coupled to NMDA receptor activation and the
intracellular activation of COX; and 3) PGs, generated locally in the spinal cord, play
a role in the cellular events that underlie hyperalgesia.
1.7 Central Prostaglandins and Aflodynia
The ability of PGs to sensitize spinal cord neurons to high-threshold (C-fiber)
somatosensory input raises an important question about their possible role in
abnormal pain states (e.g., neuropathic pain and allodynia). Specifically, do low
threshold mechanoreceptive (AI3) primary afferent fibers activate a similar
prostanoid-sensitlzing mechanism in the spinal cord in allodynia?
Preliminary evidence suggests that the answer to this question is yes.
Intrathecal ketorolac or S (+)-ibuprofen suppressed the hair deflection (HD)-evoked
increase in heart rate, blood pressure and catechol olOdation current in the locus
coeruleus of i.t. strychnine-treated rats (Hall et aI., 1999). The inactive R (-) isomer
of ibuprofen was without effect indicating thai the attenuation of these allodynic
responses was related 10 the inhibition of COX in the spinal cord. Messenger RNA
hybridization analysis revealed a 3-fold increase above control in the level of COX-2
mRNA in the rat lumbar spinal cord 2-4 h after unilateral intraplantar injection of
Freund's complete adjuvant (FCA) (Hay et at, 1997). This was followed by a
significant increase in the spinal concentration of6-keto PGF lQ and PGE2 (maximal
effect 8 h after FCA injection). These changes were temporally correlated with a
decrease in the weight-bearing capacity of the affected paw (a quantitative measure
of allodynia). The s.c. administration of indomethacin, or the COX-2 selective
inhibitor, f1osulide, attenuated the increase in spinal PG concentration. and inhibited
allodynia by 80-100%. These drugs had no effect on the development of
mechanical hyperalgesia (Hay et al., 1997). The results of these studies provMje
indirect evidence for the role of spinal PGs in the development ofallodynia. whether
induced by peripheral inflammation or by central disinhibition.
If spinal PGs are relevant to the cellular changes that underlie allodynia in the
eNS, then their direct injection into the spinal subarachnoid space should yield a
measurable allodynic state. The i.t. injection of PGE2• PGD2 or PGF2a in conscious
mice elicited dose-dependent, touch-evoked agitation. The allodynic effect of PGE2
was blocked by tha receptor antagonist. NON·NT·Q12 suggesting that this was
mediated by EP1 receptors (Uda et al .. 1990; Minami at a!., 1995b). Delivery of
PGE2 through a microdialysis probe implanted in the spinal subarachnoid space of
rats triggered an immediate increase in the concentration of glutamate, aspartate,
taurine. glycine and GASA in dialysate samples (Malmberg et at. 1995a). These
neurochemical responses were temporally correlated with the onset and decline of
behaviourally-defined allodynia (Malmberg et a!.. 1995a). The combination of PGE2
(1 0 ~M) and capsaicin (0.1 or 1.0 ~M). concentrations that individually had no effect,
evoked a significant increase (60-100%) in glutamate, aspartate, taurine, glycine
and GABA concentration and produced tactile allodynia. Thus, the introduction of
exogenous PGs into the spinal subarachnoid space induces neurochemical
changes and behavioural responses consistent with the development of tactile
anodynia in experimental animals. However, the localization and spinal
pharmacology of this prostanoid modulation have not been well investigated.
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especially in the bicuculline model of allodynia.
1.8 Hypothesis and Specific Objectives
Increased glutamatergic tone activating spinal NMDA receptors leads to a
state of facilitated neurotransmission of high-threshold (C-fiber) input and
hyperalgesia in the spinal cord. PGs, synthesized and released within the CNS in
response to C-fiber input, appear to playa major role in this facilitation. Sustained
C-fiber activity induces a rapid increase in the expression of COX-2 and the
synthesis of PGs. Because this central sensitization process is dependent on
NMDA-receptor activation, it is normally only recruited by high-threshold
(nociceptive) input.
AUodynia is an abnormal sensory state in which pain is triggered by
innocuous stimuli. Peripheral or central nerve injury appears to reduce the
functional tone of spinal glycine and/or GABAA inhibitory modulation, thereby
permitting innocuous tactile stimulation to be interpreted as pain. Indeed, the
pharmacological blockade of spinal glycine receptors with Lt. strychnine or GABAA
receptors with i.t. bicuculline induces a selective and reversible allodynic state. In
lightly anaesthetitized rats given i.t. strychnine or bicuculline, HD induces
cardiovascular, motor and neurochemical responses comparable to those evoked
by noxious thermal, mechanical or chemical stimulation in the absence or
bicuculline or strychnine (Sherman and Loomis, 1994, 1995; Khandwala et al.,
1997; Loomis et al., 2001). The hypothesis of this thesis research is that during
allodynia, low threshold mechanoreceptive input activates a PG-mediated
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sensitization mechanism in the spinal cord. The overall goal of this research was
to characterize the spinal pharmacology of bicueulline-aJlodynia with an emphasis
on the role of spinal PGE2 (the prostanoid most frequently associated with facilitated
pain states in the spinal cord). The specific objectives of the research were:
1. To determine the magnitude and area ofallodynia following the single topical
application of bicucuUine to the dorsal surface of the rat spinal cord (spinal
topical application).
2. To determine the time course and area of allodynia following repeated spinal
topical application of bicuculline.
3. To determine the effect of the COX-2 inhibitor, NS·398, on allodynia
following spinal topical application of bicucuilline.
4. To determine the effect of AP-7 (an NMDA receptor antagonist) and SC-
51322 (EP-receptor antagonist) on allodynia following spinal topical
application of bicuculline.
5. To determine the effect of i.t. AP-7 and SC-51322 on 1.1. PGE2-induced
allodynia in conscious rats.
6. To determine effect of i.t. pretreatment with bicuculline on PGE2·induced
allodynia in conscious rats.
2 METHODS
2./Animals
All experiments were conducted using male, Sprague-Dawley rats (330-4oog
at the time of experiments), obtained from the Vivarium of Memorial University of
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Newfoundland. Animals were housed in the Animal Care Facility. with a room
temperature of 220 C. and a 12 h light-dark cycle (lights on 0700 h). Rats had free
access to rat chow and tap water. All experiments were performed in accordance
with the guidelines of the Canadian Council on Animal Care and were approved by
the Memorial University Animal Care Committee.
2.2 Anaesthetized Animal Experimentation
2.2.1 Laminectomy and Recording
Surgical anaesthesia was induced with halothane (4% in oxygen) until the left
jugular vein was cannulated. Thereafter, anaesthesia was maintained with i.v,
urethane (10% w/v in saline; Sigma Chemical. Inc.). The initial dose of urethane
(1.1g1kg) was infused slowty over 5-10min as the anaesthetic effect of halothane
declined. Anaesthesia was supplemented with i.v. urethane (O.1g1kg) as required
during the experiment. The trachea was cannulated and the animal was allowed
to breathe spontaneously. The left carotid artery was cannulated for monitoring
blood pressure and heart rate. The incision was then dosed and the rat was placed
in a supine position for laminectomy.
A skin incision (3-4cm in length) was made along the midline of the back.
corresponding to the thorace-Iumbar region of the spinal cord. The muscles were
then separated from the spinal column by blunt dissection. The spinous processes
and part of the laminae of the vertebrae (T13-L1) were removed carefully using a
rongeur. The rat was then placed in a stereotaxic apparatus (Narishige, Tokyo,
Japan) with the head firmly secured using ear bars. The dura mater and arachnoid
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membrane were gently removed with the aid of a dissecting microscope to expose
the dorsal surface of the spinal cord. Endogenous CSF production was sufficient
to keep the exposed surface of the spinal cord (length by width, 1.5 x 0.5cm) from
drying throughout the experiment. Excess CSF was absorbed with a soft paper
wick.
Blood pressure and heart rate were continuously monitored using a pressure
transducer (P23XL) and polygraph (Model 79E, Grass Instruments, Mass, USA).
Cortical EEG activity was recorded continuously using two subcutaneous needle
electrodes (E2, Grass Instruments) placed 2 mm left of the midline, one extending
rostrally, entering the skin near bregma, the other extending caudally, entering the
skin about 2 mm caudal to the first. Body temperature was maintained at 36-37°C
with a thermostatically regulated blanket (Harvard Apparatus). The animal was
allowed to stabilize for at least 1h before experiments. All the experiments were
conducted al a light plane of anaesthesia. Light anaesthesia was defined as the
presence of an EEG pattern fluctuating between synchrony and desynchrony, with
synchrony present for not more than 60% of the time (Sherman and Loomis, 1994).
Animals were killed with an overdose of urethane at the end of the experiment.
2.2.2 General Protocol
Following a 1-h stabilization period, rats were given a single application of
0.9% saline (0.1 Ill) to the dorsal surface of the spinal cord. Brushing the hair (HD;
hair deflection) was performed with a cotton-tipped applicator using no more force
than required 10 move the applicator through the hair such that only the pelage was
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disturbed. The HD stimulus (2-min duration repeated every 5 min) was applied
bilaterally to the caudal dermatomes including the hind leg, foot and lower back.
Allodynia was induced by applying bicuculline (in 0.1 ~I sterile saline) to the left or
right side of the spinal cord followed 5 min later by HD. The HD stimulus was used
to identity the sites of allodynia; subsequent stimulation was restricted to that
sites(s). The maximum HD-evoked change in mean arterial pressure (MAP). heart
rate (HR) and the duration of motor responses (MR) were recorded as previously
described (Sherman and Loomis, 1994). HD was repeated every 5 min until no
evoked responses were detected. All animals were allowed to recover for at least
30 min before further drug application.
To determine the dose-response relationship of spinal topical bicuculline,
four separate sub-convulsive doses (0.01,0.03,0.1,0.3 I-Ig)were tested (maximum
of 2 doses per animal). In separate animals, the effect of repeated spinallopical
dosing with bicucutlinewas also determined (0.1 I-Ig bicuculline given once every 20
min for 2h). All drugs were applied to the same site on the spinal cord as defined
by anatomical landmarks observed through the dissecting microscope (Olympus
255040, Tokyo, Japan).
In a further group of rats, 0.1 J.!g of bicuculline (in 0.1 J.!I saline) was given
topically to the spinal cord as a positive control test. After a complete recovery from
allodynia, rats were pretreated with one of the following: NS-398 (0.1, 1.0, 1.5. 5.0
J.!g), 20-min pre-treatment; SC-51322 (0.1, 1.0, 4.0, 8.0 J.!g), 15-min pre-treatment;
and AP·7 (0.01, 0.1, 1.0 J.!g), 20-min pre-treatment. Bicuculline (0.1 J.!g) was
repeated every h thereafter until the effects of the pretreatment had completely
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disappeared. The maximum HD-evoked change in MAP, HR and MR following
each dose of bicucuUine was determined. All drugs, induding bicuculline, were
applied to the same site on the dorsal surface of the spinal cord.
To examine the extent of drug diffusion after topical drug administration to
the spinal cord, a fluorescent tracer, bisbenzimide, was added to the bicuculline
solution (0.1% w!v each) and applied to the dorsal spinal cord. Twenty minutes
later, the animals were perfused with 4% paraformaldehyde transcardiatly and
spinal cords (2 em, including lumbar segments)were removed. Transverse sections
(40 j..lm) of the lumbar spinal cord were cut using a vibratome (Vibratome Series
1000 Technical Products International, Inc. St. Louis, MO, USA). The sections were
analyzed and photographed under UV illumination using a fluorescent microscope
(Can Zeiss MC 63, Germany).
2.2.3 Drugs
Bicucul1ine IH..bicuculline methiodide, MW: 509.3], AP-7 (+/-)-2-amino-7-
phosphono-heptanoic acid, MW: 219.2), and bisbenzimide
(2'-14·ethoxyphenyfl ..5-[4-methyl"1 ..piperazinyfJ..2,5'·bi..1H·benzimidazole) were
obtained from Sigma (St. Louis, USA). NS-398
[N-(2..cyclohexyloxy--4..nitrophenyl)·methanesulfonamide, MW: 314.4] and
SC-51322 [8..chlorodibenz(b,f)(1 ,4}oxazepine..10i11 H]-carboxyl acid, 2-(3-(2-[fury-
anylmethyl}thio)..1-oxopropyl)hyrazide: MW: 457.9) and were purchased from
BIOMOL Research Laboratories Inc. (Plymouth Meeting, USA). Bicuculline and
Ap..7 were dissolved in 0.9% sterile saline (Astra Pharma Inc.). Bisbenzimide was
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dissolved with bicuculline in sterile saline. NS-398 and SC·51322 were dissolved
in 70% and 90% DMSO (in water), respectively (BDH Inc., Toronto, Canada).
The volume of drug solution applied to the dorsal surface of the spinal cord
ranged from 0.05-0.2 ~1. All drugs were administered by means of a hand-held
microsyringe (1 Ill) with the aid of a dissecting microscope (Olympus 255040,
Tokyo, Japan). Specific structures on the dorsal surface of the spinal cord such as
blood vessels and nerve root bundles were used as landmarks to apply drugs
precisely to a specific site each time. Drugs were applied immediately after soaking
up the CSF with a paper wick. Only one dose of a pretreatment drug was used in
each animal.
2.2.4 Data Analysis
The maximum HD-evoked change in MAP(mm Hg), HR (bpm) and MR (min)
was used for all data analyses. The change in MAP and HR was calculated relative
to the immediate pre-stimulus control (not relative to T=O). The maximum change
in MAP or HR observed in the 1-minute interval immediately before stimulus
application was subtracted from the maximum value observed during HD.
Variability associated with single measurements is indicated by the SEM, while
variability associated with blocks of data is indicated by the pooled 95% confidence
intervals (95'''IoCI). Repeated measures one-way analysis of variance (ANOVA)
followed by the Neuman-Keuls multiple comparison test was used to detect
statistical differences within treatment groups over time (pretreatment data).
Completely randomized ANOVA followed by the Neuman-Keuls multiple
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comparison test was used to identify statistical differences between treatment
groups (dose·response data). Dose-response curves were fttted using least
squares regression analysis. P<O.05 was considered to be statistically signifICant.
The methods of data analysis were based on general statistics texts and the
program Sigmastat for Windows Version 2.03 (SPSS Inc.).
2.3 Conscious Animal Experimentation
2.3.1 Implantation of Intrathecal Catheter
The i.t. catheter was constructed from a segment of PE·1 0 tubing stretched
to two times its original length to reduce its diameter. A small loop was made at one
end of the tubing and secured with nail polish. The tubing was cut to a length of 8.5
cm from the loop for insertion into the spinal subarachnoid space. The tubing was
filled with sterile saline before implantation.
Surgical anaesthesia was induced by placing the rat in a transparent
plexiglass box filled with 4% halothane in oxygen. The rat was then transferred to
a stereotaxic apparatus (Narishige, Tokyo, Japan) with the head firmly secured
using ear bars. Anaesthesia was maintained with 2.5% halothane in oxygen. The
hair was shaved at the back of the head and swabbed with 10% povidone iodine
topical solution U.S.P. and 75% ethanol. An incision (approximately 1 em in length)
was made along the midline at the base of the skull. The muscles were cut
transversely and carefUlly separated to expose the dural membrane of the cisterna
magna. A small puncture was made in the dural atlant<K>ccipital membrane using
a 16G needle. Leakage of a small amount of cerebrospinal fluid (CSF) through the
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hole verified penetration into the subarachnoid space. This was immediately
absorbed with a cotton-tipped applicator.
The i.t. catheter was inserted through the hole and carefully guided 8.5 em
caudally in the spinal subarachnoid space so that the catheter tip reached the LS-L6
spinal segments. The catheter was anchored in place by suturing the fixed loop at
the rostral end to the overlying muscle and skin. The rostral tip was externalized
through the skin on the top of the skull and sealed with a stainless steel plug. The
incision was closed with sutures and swabbed with 10% povidone iodine solution.
Ten ml of norma! saline was then injected s.c. on the back of the animal for
hydration.
Rats recovering from anaesthesia were immediately observed for signs of
neurological damage, including hind limb weakness or paralysis, abnormal gait,
locomotordifficulty and atypical behaviour. Rals free of neurological sequelaewere
returned to the Animal Care Facility where they were housed individually in regular
plexiglass cages. They were allowed to recover for at least 3 days prior to
experimentation. Animals exhibiting symptoms of neurological damage were
immediately killed by an overdose of urethane.
2.3.2 General Protocol
On the day before the experiment, rats were transported from the Animal
Care Facilityto a quiet behavioural room in the research laboratory. They were kept
in their home cages at a room temperature of 22° C using a 12-h light-dark cycle
(lights on 0700 h). Free access to rat chow and tap water was provided. All
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behavioural experiments were conducted at the same time period (14:00-20:00 h)
each day. Rats were gently and repeatedly handled by the investigator for one h
before the start of the experiment. During this time. rats were also brushed with a
cotton-tipped applicator at 5-min intervals to acclimatize them to the HD stimulus.
All drugs were injected i." by slow infusion (20 pi over 1.5-2 min). Injections were
made using a hand-held 25-pl microsyringe to which was attached a segment of
PE-lO tUbing. The latter was used as a flexible extension to connect the
microsyringe to the externalized tip of the Lt. catheter. Drug solutions were loaded
into the PE-10 extension from the microsyringe such that all drugs were injected in
a volume of 10 pi and flushed with 10 ~I of normal saline (i.t. catheter volume: 6-8
To assess baseline responses, animals were injected with 20 ~I of normal
saline (equivalent to 10 pI of drug solution + 10 ~I saline flush) and continuously
observed for spontaneous (without HD) and HD-evoked behaviour. These were
scored according 10 the systems described below, One h later, a single dose of
PGE2 (0.8, 3.0, 8.0, 20 pg) or vehicle (3% ethanol in water) was injected and the
behavioural scoring repeated until no further spontaneous or evoked responses
were observed. In separate experiments (designed to study the pharmacology of
the PGE2-allodynia), a fixed dose of PGE2 (8 pg) was injected Lt. in rats pretreated
with one of the following: AP-7: (0.4 pg), 20-min pretreatment; SC-51322: (6, 30,
100 ~g), 15-min pretreatment: Bicuculline: (0.01 ~g), 5-min pretreatment: or Vehicle:
water or 90% DMSO in water. The spontaneous and HD-evoked behaviours were
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scored as described below. All animals were monitored individually throughout the
experiment and were used no more than twice. Rats were killed with an overdose
of urethane. In all experiments, the investigator was blinded to the identity of the
drug/vehicle treatment.
2.3.3 Behavioural Scoring System
The protocol for the evaluation of behaviour, with and without HD, is
illustrated in Figure 3. The behaviour of each rat observed without HD was
monitored continuously for a 4-min period. The maximum score achieved was
recorded in a computer every 30 sec for a total of 8 scores per rat per 4·min
observation period. At the conclusion of this observation period, HD was applied
continuously for 1 min to the affected dermatome{s). The latter were determined
by brushing the hair over the back, flanks, limbs, and hind paws until a response
was observed. The maximum score evoked by HD was recorded in a computer at
the end of the 1-min stimulus period. This cycle was then repeated until no
behavioural responses (spontaneous or HD evoked) were detected.
Behaviour in the absence of HD was rated using the following scoring system (as
modified from Malmberg et al., 1995a, and Ishikawa et al., 2000).
Score Behaviour
Normal behaviour (bright, alert, and exploring)
Huddling, burrowing or hiding
One of the following: stationary with one paw elevated, limping
on movement, piloerection, occasional vocalization, attention
directed to the affected site
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~Figure 3. Protocol for the evaluation of behaviour in conscious PGE2 treated rats.
I 11 21 31 41 51 61 71 61 91 101 111 121 131 141 151 161 171 181 191 201 211... (M;n)
Note: Each number Indicates the Ume in minutes. Intrathecal PGE2 was given at time t=O. The solid bars under the
time scale indicate the time periods during which HD-evoked behaviour was evaluated. During Intervals indicated by
intefTUpted line. the behaviour in the absence of HO stimulus was scored. All behaviour was scored according to the
scale modified after Malmberg (Malmberg and Yaksh 1995a).
Score Behaviour
Two or more of following together: stationary with one paw
elevated, limping on movement, piloerection, occasional
vocalization, attention directed to the affected site
Frequent vocalization, circling (very agitated), licking, biting
and scratching the affected dermatome(s)
HD·evoked behaviour was rated using the following (as modified from Malmberg et
aI., 1995a, and Ishikawa et aI., 2000):
Score Behaviour
Normal (curious. responsive and exploring)
Moderate effort to escape: walking away from the stimulus
source (avoidance) or protecting the affected dermatome(s)
Moderate agitation: paw withdrawal. piloerection (back and
flank), or occasional vocalization upon stimulation
Strong agitation (two or more of the following together): paw
withdrawal; piloerection (back and flank); occasional
vocalization upon stimulation
Vigorous effort to escape: attacking the applicator, frequent
and persistent vocalization, circling the cage, licking, biting and
scratching the affected dermatome(s)
2.3.4 Drugs
PGE2 and SC-51322 were purchased from BIOMOl Research Laboratories,
Inc. (Plymouth Meeting, USA). AP-7 and bicuculine were purchased from Sigma
Chemical Co. (St. louis, MO, USA). PGE2 was dissolved in ethanol and diluted with
sterile saline such that the maximum concentration of ethanol never exceeded 3%
(vlv). AP-7 and bicuculline were dissolved in 0.9% sterile saline (Astra Pharma
Inc.). SC-51322 was dissolved in OMSO (max 90% in water. SOH Inc.• Toronto.
Canada). All drug doses were administered in a volume of 10 ~.
2.3.5 Verification of Catheter Position
After the completion of the experiment, animals were injected with 10 ~I of
5% lidocaine followed by 10 ~I saline. Rats were observed for evidence of hind limb
weakness or paralysis, indicative of the correct placement of the spinal catheter at
the L5 or L6 lumbar levels. A laminectomy was also performed to visually confirm
the position of the Lt. catheter in randomly selected rats.
2.3.6 Data Analysis
For behaviour observed without HO stimulation. the average of 8 scores was
calculated for each rat per 4-min observation period and expressed as the percent
of the maximum possible score (4). The HO-evoked score for each rat is also
expressed as the percent of the maximum possible score (4). Time-course data
represent the mean ± SEM of the percent maximum possible score of all animals
in each treatment group. The cumulative behavioural score was calculated from the
entire time-course curve (120 min) for each rat (equivalent to the area-under-the-
time-course curve). Dose-response data represent the mean ± SEM of the
cumulative behavioural scores for each dose of PGE2• Completely randomized
ANOVA followed by the Neuman-Keuls multiple comparison lest was used to
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identify the statistical differences between multiple treatment groups (dose-response
data). The paired Student t-test was used to detect significant differences between
two experimental conditions (before and after pretreatment) within animals. P<0.05
was considered to be statistically significant.
3 RESULTS
3.1 Spinal Topical Bicuculline-Induced Alfodynia in Anaesthetized Rats
3.1.1 Unilateral Application of Bicuculline to the Spinal Cord Induces Localized
Allodynia
Mild brushing of the hair (HD) with a cotton-tipped applicator evoked no
cardiovascular changes or molor responses after saline application (0.1 1-11) to the
dorsal surface of the spinal cord (Figure 4B). In contrast, an identical HD stimulus
applied to the hind leg or foot ipsilateral to the site of bicuculline application evoked
a progressive increase in mean arterial pressure (MAP) and heart rate (HR) (Figure
4C) that persisted beyond the duration of HD. The allodynia arising from this
unilateral treatment was normally restricted to a circumscribed area such as a single
digit or the area between two digits on the ipsilateral hind paw (Figure 4G, Table 1).
Maximum HD-evoked cardiovascular responses were normally observed during the
first 2-min stimulus (5 min after bicuculline). These were accompanied by abrupt
motor responses (MR) on the affected side (e.g .• withdrawal of the hind leg, kicking,
and/or scratching), as well as desynchrony of the EEG (Figure 4).
The cardiovascular responses disappeared gradually (0.5-3 min) after the
discontinuation of HD. In most cases, termination of HD coincided with a change
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Figure 4. Representative tracings ofhair-deflecUon (HD).evoked changes In blood pressure, heart rate and
EEG in a ureth.ne.-anesthetized rat. The top trace in each panel denotes time. HD (2 min duration), applied
before and every 5 min after SIC, Is Indicated by the solid bar below the time trace. All the drugs or vehicle
were applied topically to the right or left side of the dorsal spinal cord (see Methods). A fixed dose of BIC (0.1
~g) was used. A: Before any drug administration. B: 5 min after saline (0.1 ~I) on the right side; HD on the
W
Cf right side. C: 5 min after SIC (0.1 ~g) on the right side; HD on the right side. 0: 25 min after NS·398 (1.0j.lg),
5 min after BIC (SIC was applied 20mln later after NS..J98. Both agents were applied to the same spot on the
right side), HD on the right side. E: 2 h after NS..J98 on the right side, 5 min after SIC (0.1 I-1g) on the left side
(contralateral to NS..J98 site), HD on the left side. F: 3 h after NS..J98, 5 min after BIC (0.1 ~g) on the same site
as NS..J98 (right side), HD on the right side. G: Shading Indicates ttl!.areas ofailodynla on the right hind paw
following topical application of BIC (0.1 ~g) to the right side oftha dorsal spinal cord.
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Table 1. Comparison of Topical and Intrathecal BicucuJline-
Induced AlJodynia in the Rat.
Parameters
Cardiovascular and
motor responses at
equi-effective dose
Topical
MAP: 18.5 i 3.21mmHg
HR: 35±5.75bpm
MR: 30.83 ± 3.96 min
(BICO.1.,.g)
Intrathecal§
MAP:16.67 ± 1.66 mmHg¥-
HR: 30.83 ± 3.96 bpm'
MR: 35i5min'
(BICO.75~g)
InJectJonvolume
Area of allodynia
0.1 f.ll (on spinal cord) 5 ~ (into CSF)
Unilateral, highly restricted Bilateral, large
(e.g., one digit on hind paw) (e.g., flanks and hind legs)
Duration of anodynia 30 min after single dose. 20-30 min
sustained up to 2 h with
reoeated dosino.
Drug delivery Multiple sites available for Single route into spinal CSF
topical application on spinal
surface
Abbreviations: MAP: mean arterial pressure
HR: heart rate
MR: motor response
CSF: cerebrospinal fluid
... No significant difference compared with the corresponding values from
topical BIC administration.
§ Data from Loomis et al., 2001.
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in the EEG from a desynchronous to a synchronous pattern. The HD-evoked
cardiovascular responses outlasted the motor responses; the former persisted for
an additional 5-10 min. The duration of bicuculline-allodynia (from the time of drug
application until the disappearance ofcardiovascular responses) ranged from 30-50
min for 0.1 /-lg bicuculline, and increased with bicuculline dose. There was a linear
relationship between the log dose of spinal bicuculline (0.01-0.3 ).1g) and the
maximum HD-evoked change in MAP, HR, and MR (Figure 5). The corresponding
ED5(I values and 95% confidence intervals (CI) are shown in Table 2. Allodynia
remained localized to the ipsilateral hind paw with all bicuculline doses, and there
was no detectable expansion of the allodynic area over time.
3.1.2 Multiple Doses of Bicuculline Induce Sustained Allodynia
When repetitive doses of bicuculline (0.11Jg) were applied to the same site
on the left or right side of the spinal cord every 20 min, allodynia was sustained for
up to 2 h. As shown in Figure 6, HD-evoked responses in MAP, HR and MR were
significantly different from their respective control after each dose of bicuculline (n
= 5-9). There were no significant differences across the 6 doses of bicuculline
within each evoked response (MAP, HR and MR). In addition, there was no
detectable change in the location ofallodynia overtime, norwas there an expansion
of the allodynic area with the mUltiple bicuculline dosing.
3.1.3 Distribufion of Drug Solution after Topical Application to the Spinal Cord
To assess the extent of drug distribution, bisbenzimide was added to the
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Figure 5. The dose-response relationship of topical bicuculllne (BIC) on hair deflocllon-evoked changes in
mean arterial pressure (MAP; Panel AI, heart rate (HR; Panel B) and motor responses (MR; Panel C).
Bicuculiine (0.01, 0.03, 0.1, 0.3 1-19) was applied topically on the left or right side of the dorsal spinal cord (see
Methods). Doses greater than 1.0"'9 produced exaggerated allodynla and convulsions In the lower quadrants
and were excluded from the data analysis. Each point represents the mean ± SEM of 5-8 rats. The solid line
is the least squares regression line and the dashed lines Indicate the 95-;' confidence Intervals (el). The ED50
values and 95% CI are listed in Table 2.
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Table 2. EDso Values and 95% Confidence Intervals (CI) of Spinal
Topical Application of Bicuculline
Parameters ED" (95% GI) (~g)
Mean Arterial Pressure 0.055 (0.035-0.085)
Heart Rate 0.075 (0.048-0.118)
Motor Response 0.097 (0.078-0.122)
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Figure 6. The maximum hair deflection-evoked change in mean arterial
pressure (MAP), heart rate (HR) and motor response (MR) after repeated doses
of bicuculline. Bicuculline (0.1 ~g) was applied unilaterally to the same site
on the dorsal spinal cord every 20 min for 2 h. All points are significantly
different from their respective (saline) control (P < 0.05). Each point
represents the mean ± SEM of 5-9 rats.
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bicucuUine solution (0.1 % vlw for bisbenzimide and bieuculline). Fluorescence was
restricted to the ipsilateral dorsal spinal cord following either a single application
(Figure 7C and 0) or 6 consecutive applications of the bisbenzimideJ bicuculline
solution (Figure 7A and B). Penetration of the fluorescent tracer was dearly
observed in the superfICial laminae of the dorsal hom (laminae I-III) (Figure 7A,
Figure 70). In contrast, i.t. bisbenzimide displayed an extensive bilateral distribution
over the surface of the spinal cord (data not shown).
3.2 Inhibitory Effect of COX the Inhibitor, NS-398 on Bicuculline-Allodynia
After complete recovery from bicuculline allodynia (control), animals were
pretreated with NS·398 (1.0 I-Ig) 20 min before further bicuculline (0.1 IJg)
application. Both drugs were applied unilaterally to the same site on the spinal cord.
Figure 8 illustrates the time.course of inhibition of allodynia by N5-398 (1 ~g). All
indices of b+cuculline-allodynia were significantly reduced. The maximum inhibition
achieved with this dose of N$-398 was 66% for MAP. 70% for HR and 62% forMR,
and lasted for 1-2 h (Figure 8, Figure 4). The inhibitory effect of NS-398 was
confined 10 the ipsilateral spinal cord. When bicuculline (0.11J9)was applied 10 the
mirror site (contralateral side) 2 h after NS-398 (time of near maximal inhibition;
n=3), no attenuation of allodynia was observed (Figure 4E).
As shown in Figure 9, the inhibitory effect of NS-398 was dose-dependent
(n=5-8 for each). The 1050 values ranged from 0.49-0.91 I-\g, although these were
not significantly different from one another (Table 3). The maximum inhibitory effect
of NS-398'obtained with the highest dose tested (5 f.lg) was 81% for MAP. 86% for
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Figure 7. Fluorescent photomicrograph showing transverse sections of
the left and right lumbar dorsal horn. Rats received either mUltiple doses
of a bicucullinelbisbenzlmlde (0.1"10 wlv each) solution applied to the dorsal
surface on the left side of the spinal cord every 20 min for 2 h {Al, or a single
dose of the same solution on the right side of the spinal cord (D). All doses
were delivered In a volume of 0.1 III (see Methods). The animals were
pertused transcardlally 20 min after the last dose. Note that fluorescence is
restricted to the drug application side of the drug application (A, B: repeated
dose; C, 0: single dose). Fluorescence was evident in lamina I-III of dorsal
horn after repeated (A) or single drug application (D). Scale bar, 100 pm.
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Figure 8. Time course of the inhibitory effect of NS-398 (1.0 fig) on the
maximum hairdeflection (HO)-evoked change in mean arterial pressure (MAP),
heart rate (HR) and motor responses (MR) in bicuculline (BIC)-treated rats.
Control indicates the HD-evoked responses to BIC (0.1 fig) before NS-398.
Animals were pretreated with NS-398 twenty min before BIC (0.1 I-1g). Both
drugs were applied topically to the same site on the dorsal spinal cord. HO-
evoked responses were determined 20min, 1h, 2h and 3h after NS-398; BIC
(0.1 119) was applied immediately before each time point. The maximum HO-
evoked change in HR, MR and MAP occurred five mIn after each BIC
application. Each column represents the mean ± SEM of 5-8 rats. The
asterisk at each time point indicates a significant difference from the
respective control (P < 0.05). NS-398 reduced all the indices of BIC-induced
allodynia.
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Figure 9. The dose-response relationship of NS-398 on hair deflection (HD)-evoked allodynia In bicuculllne
(BICHreated rats. Rats were pretreated with NS·398 (0.1, 1.0, 1.5 or 5.0 ~g) fifteen min before BIC (0.1 ~g).
Both drugs were applied topically to the same site on the dorsal spinal cord (see Methods). Maximum HD-
evoked changes In mean arterial pressure (MAP; Panel A), heart rate (HR; Panel B) and motor responses (MR;
Panel C) are shown. Each point represents the mean ± SEM of S-8 rats. The solid line Is the least squares
regression line and the dashed lines Indicate the 95% confidence intervals (CI). The slopes ofthe regression
lines were significantly different from 0 (slope P ~ 0, one-way AN OVA, P < 0.05). The IDS(! values and 95% CI
are listed in Table 3.
Table 3. Summary of the IDso Values and 95% Confidence Intervals
(CI) for NS-398, AP-7 and SC-51322 in Bicuculline-Treated Rats.
DRUGS MAP HR MR
NS-398 (~g) 0.50 (0.32-0.79) 0.49 (0.27-0.94) 0.91 (0.38-1.32)
AP-7 (~g) 0.23 (0.09-0.56) 0.17 (0.07-0.42) 0.09 (0.01-0.31)
SC-51322 (~g) 2.11 (0.65-6.86) 1.36 (0.67-2.75) 1.74 (0.91-3.32)
Note: All drugs were applied unilaterally to the dorsal surface of the spinal
cord (see Methods). Allodynia was evoked by repeated hair deflection to the
affected dermatome(s). The dose-response curves are shown in Figure 9,10,
and 13. Abbreviations: MAP - mean arterial pressure; HR· heart rate; MR-
motor response.
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HR and 75% for MR. Vehicle pretreatment (OMSO 70% + 30% water) had no
significant effect on bicuculline-allodynia.
3.3 Inhibitory Effect of NMDA Receptor Antagonist, AP-7 on Bicucufline-Allodynia
Following complete recovery from bicuculline allodynia (control), rats were
treated with AP-7 (0.01,0.1, 1.0, or 4.0 Ilg) for20 min. Bicuculline, applied topically
to the same site of the spinal cord, was given 20 min, 1 hand 2 h after AP-7. The
HO-evoked cardiovascular and molar responses were doslHtepenclently inhibited
by AP-7 (n = 4-6 for each dose) (Figure 10). The 10sovalues and 95%CI shown in
Table 3 were obtained at the Ume of maximum inhibition (i.e. the first dose of
bicuculline after AP-7).· The time course of the inhibitory effect of AP-7 (0.1 I-1g) on
bicuculline-allodynia is shown in Figure 11. At the maximum dose of 4 Ilg, AP-7
produced an almost complete blockade of bicuculline allodynia (Figure 10). The
cardiovascular responses 10 phasic noxious pinch remained unaltered after AP-7
(data not shown).
3.4 Inhibitory Effect ofEP-ReceptorAntagonist SC-51322 on Bicuculfine-Aflodynia
Pretreatment with SC-51322 (0.1. 1.0, 4.0, 8.0 }lg) 15 min before bicuculline
(0.1 }lg) attenuated the HO-evoked cardiovascular and motor responses of
bicuGulline·allodynia. Figure 12 shows the time course of the inhibitory effect of 4.0
Ilg of SC-51322 on bicuculline·allodynia. This inhibitory effect was statistically
significant from control for up to 2 h. This effect was also dose-dependent (n =4-6
for each dose)(Figure 13). yielding 1050 values of2.1, 1.4 and 1.7}lg for MAP. HR
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Figure 10. The dose~esponse relationship of AP-7 on hair deflection (HD)-evoked allodynia In blcuculline
(Ble)-treated rats. Rats were pretreated with AP-7 (0.01, 0.1, 1.0 or 4.0 I-IQ) twenty before BIC (0.1 1-19). Both
drugs were applied topically to the same site on the dorsal spinal cord (see. Methods). Maximum HD-evoked
changes in mean arterial pressure (MAP; Panel AI, heart rate (HR; Panel B) and motor responses (MR; Panel
C) are shown. Each point represents the mean:!: SEMof 5-8 rats. The solid line is the least squares regression
line and the dashed lines indicate the 95"10 confidence Intervals (CI). The slopes of the regression lines were
significantly different from 0 (slope 13 .,. 0, one-way ANOVA, P < 0.05). The corresponding ID50 values and 95"10
CI are summarized in Table 3.
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Figure 11. The time course of the inhibitory effect of Ap·7 (0.1 Ilg) on the
maximum hair deflection (HDI~vokedchange in mean arterial blood pressure
(MAP), heart rate (HR) and motor responses (MR) in bicuculline (BIC)·treated
rats. Control indicates the HO~voked responses to SIC (0.1 Ilg) before AP-7.
Animals were pretreated with AP·7 twenty min before BIC (0.1 J.L9). Both drugs
were applied topically to the same site on the dorsal spinal cord. HO-evoked
responses were determined 20min. 1h, 2h and 3h after AP-7; SIC (0.1Ilg) was
applied immediately before each time point. The maximum HO-evoked change
in HR, MR and MAP occurred five min after each BIC application. Each
column represents the moan :t SEM of 5-8 rats. The asterisk at each time
point indicates a significant difference from the respective control (P < 0.05).
AP·7 reduced all the indices of SIC-induced allodynia.
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Figure 12. The time course of the inhibitory effect of SC-S1322 (4.0 Ilg) on the
maximum hair deflection (HD)-evoked change in mean arterial pressure (MAP),
heart rate (HR) and motor responses (MR) in bicuculline (BIC)-treated rats.
Control indicates the HD-evoked responses to BIC (0.1 I-1g) before SC-51322.
Animals were pretreated with SC-51322 ten min before BIC (0.1 }lg). Both
drugs were applied topically to the same site on the dorsal spinal cord. HD-
evoked responses were determined 10min, 1h and 2h after SC-S1322; BIC (0.1
f.lg) was applied immediately before each time point. The maximum HD-
evoked change in HR, MR and MAP occurred five min after each BIC
application. Each point represents the mean ± SEM of 4·9 rats. The asterisk
at each time point indicates a significant difference from the respective
control (P< 0.05). SC-51322 reduced all the indices of BIC-induced allodynia.
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Figure 13. The dose-response relationship ofSC·51322 on hair deflection (HD)-evoked allodynia in bicuculline
(BJCl·treated rats. Rats were pretreated with SC·51322 (0.1, 1.0, 4.0 or 8.0 1J9) before BIC (0.1 IJg) treatment.
Both drugs were applied topically to the same site on the dorsal spinal cord (see Methods). Maximum HD~
evoked changes in mean arterial pressure (MAP; Panel A), heart rate (HR; Panel B) and motor responses (MR;
Panel C) are shown. Each point represents the mean ± SEM of 4~ rats. The solid line is the least squares
regression line and the dashed lines indicate the 95% confidence intervals (el). The slopes of the regression
lines were significantly different from a (slope Ill- 0, one-way ANOVA, P < 0.05). The lDso values and 95"10 CI
are summarized in Table 3.
and MR. respectively (Table 3).
3.5 Intrathecal PGEzElicits AlJodyn;a-like Behaviour in Conscious Rats
3.5.1 Effects Observed in the Absence of Hair Deflection
PGEzelicited behavioural responses ranging from mild burrowing and hiding
behaviour to vocalization and biting or scratching the caudal dermatomes.
These behaviours were transient, lasting only during the period of i.t. injection, and
yielded scores in the 2-3 range. After injection, these responses rapidly decreased
in frequency and severity yielding scores in the 1-2 range (Le. 20-45% of the
maximum possible score depending on the dose). These remained relatively stable
for the next 19-29 min and declined gradually thereafter (Figure 14). The Lt.
injection of vehicle (3% ethanol in water) yielded very mild effects as indicated by
the low behavioural scores (5-10% of the maximum possible score) throughout the
observation period. Although there appeared to be some relationship between the
magnitude of the scores for the behavioural changes observed in the absence of
HD stimulation and the dose of PGEz (Figure 15), statistical analysis of the
regression line indicated that the slope was not significantly different from O.
3.5.2 Hair Deflection-Evoked Allodynia
Brushing the hair on the lower dermalomes (hind limbs, flanks or lower back)
with a cotlon+tipped applicator evoked abrupt and robust behavioural responses in
rats treated with i.t. PGEz. These included avoidance behaviour(hiding the affected
dermatome); paw withdrawal, vocalization, piloerection; and aggressive nocifensive
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Figure 14. The time course of behavioural responses without hair deflection In PGE2-treated rats. Animals
were injected with intrathecal PGEi (0.8. 3.0. 8.0 or 20 ~g) or vehicle (3% ethanol In water) at time O. Each
column represents the mean t SEM of the percent maximum possible score of 5-8 rats for each 4-mln
observation period. The only lime period that exhibited a significant dose-dependent effect was 14 min (one·
way ANOVA; P < 0.05).
PGE, OO$e(~g)
Figure 15. The dose-response relationship of intrathecal (Lt.) PGE2;
behavioural responses observed without hair deflection. Rats were injected
with Lt. PGE2 (0.8~g, 31Jg, 8IJQ and 201Jg) and behaviour was rated using a
behavioural scoring system. In all cases, the investigator was blinded to the
nature of the treatment. Each point represents the mean ±SEM of the sum of
the behavioural scores per rat overthe 2-h time course (n= 5-8). The solid line
is the least squares regression line and the dashed lines indicate the 95%
confidence intervals. The slope of the linear regression line was not
significantly different from 0 (slope ~ = 0, one-way ANQVA, P = 0.066).
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behaviours such as attacking and biting the stimulus applicator. Identical brushing
of the face, head and fore paws of PGE2-treated rats was without effect. The time-
course of HD-evoked allodynia for four separate doses of PGE2(0.8, 3.0, 8.0 and
20 I-Ig) is shown in Figure 16. Peak allodynia occurred 5-15 min after injection
depending on the dose. Recovery from allodynia was complete 90 min after
injection except for the 20 1-19 dose (Fi9ure 16). Brushing of the caudal dermalomes
in vehicle {3'% ethanol in water)-treated rals yielded very low behavioural scores
«10% of the maximum possible score; Figure 16). These were not significantly
different from those evoked by HD in i.t. saline-treated controls (data not shown).
As illustrated in Figure 17, the effect of PGE2 on HD-evoked allodynia was linear1y
related to the log of the dose. The slope of the linear regression line was
significantly different from°and the maximum allodynia appeared to occur between
3 and 20 I-Ig. Dose-response analysis yielded an ED50 and 95% CI of i.t. PGE2=2.6
'9 (1.6-4.2).
3.6 Effect ofSC-51322 on Hair Deflection-Evoked A/lodynia in PGEr Treated Rats
Pretreatment with Ll. SC-51322 (100 I-Ig), 15 min before i.t. PGE2 (81-19),
significantly reduced HD-evoked allodynia as compared to control (Figure 188).
Maximum inhibition occurred 15 min after i.l. PGE2 (30 min after SC-51322) and the
inhibitory effect remained significantly different from that of vehicle control for up to
60 min. Pretreatment with i.t. DMSO (the injection vehicle for SC-51322) had no
effect on HD-evoked allodynia in PGE2~treated rats as compared to rats treated only
with i.t. PGE2(except at 55 and 60 min after injection){Figure 188).
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Figure 16. The time course of hair deflection (HO)-evoked behavioural responses in PGE2-treated rats. Rats
were injected with intrathecal PGE2 (0.8, 3.0, 8.0 or 20 I-lg) or vehicle (3% ethanol in water) at time O. Each
column represents the mean ± SEM of the percent maximum possible score of 5-8 rats evaluated for each 5-
min observation period. All time periods exhibited a significant dose-dependent effect except 120 min (one.
way ANOVA; P < 0.05).
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Figure 17. The dose-response relationship of intrathecal (Lt.) PGE2; hair
deflection (HD)-evaked allodynia. Rats were injected with i.t. PGE2(O.8~g,3).1.9,
8).1.9 and 201-\9) and HD-evoked behavioural responses were rated using a
behavioural scoring system. In all cases, the investigator was blinded to the
nature aftha treatment. Each point represents the mean ± SEM of the sum of
the behavioural scores per rat over the 2·h observation period (n= 5-8). The
solid line is the least squares regression tine. The dashed lines indicate the
95% confidence intervals. The slope of the linear regression line was
significantly different from 0 (slope f.I ~ 0, one-way ANOVA, P = 0.0019).
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Figure 18. The time course aftha inhibitory effect ofSC-51322 in PGE2-treated
rats. Intrathecal (Lt.) PGE2 (8Ilg) was given alone orfifteen min after i.t. OMSO
(90% in water) or Lt. SC-51322 (100 Ilg). Spontaneous (A) and hair deflection
(HD)-evoked (B) behaviours were rated using behavioural scoring systems
with the investigator blinded to the nature of the treatment. Each column
represents the mean ±SEM of the percent maximum possible score of7 rats.
SC-51322 significantly inhibited PGE2-induced behaviour without HD at the 14'
and 19' time periods (Panel A), and HO-evoked behaviour at 10', 15',20',25'
and 30' (Panel B) (one-way ANOVA, P < 0.05).
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The inhibitory effect of SC-51322 on PGE2-allodynia was dose-dependent (Figure
19). The reduction in the mean cumulative behavioural score was linearly related
10 the log dose of i.t. SC-51322 over the range of doses that were tested (6, 30 and
100I-lg). At the highest dose (100 I-Ig), SC-51322 decreased the cumulative
behavioural score evoked by HD by approximately 60%; behavioural scores
evaluated between the HD tests (without HD) were reduced by 48% (Figure 20).
SC-51322 attenuated the latter (Figure 18A) in a dose-dependent manner (Figure
20), although the slope of the dose-response was markedly lower than that of the
HD-evoked responses (Figure 19).
3.7 Effect of AP-7 on Hair Deflection-Evoked Allodynia in PGE2- Treated Rats
The i.t. AP-7 experiments were conducted on another separate group of
freely moving conscious rats. In order to prevent any nonspecific effect of AP-7
such as immobilization, pilot experiments were performed to choose a maximum
dose of AP-7 devoid of any overt behavioural effect. Intrathecal injection of AP-7,
at a dose less than 0.4 I-Ig, did not induce any obvious behavioural changes or
decreases in mobility. Thus, a maximum dose ofO.4l-1g (in 51-11 saline) was chosen
for i.t. injection. Pretreatment of the rat with AP-7 (0.4 I-IQ) 20 min before PGE2 (8
I-Ig) significantly attenuated the HD-evoked allodynia-like responses. The inhibitory
effect became significant 15 min after PGE2 treatment, then gradually decreased
and disappeared 90 min thereafter (Paired t test, P < 0.05, Figure 21). The mean
cumulative behavioural score of HD-evoked responses was significantly decreased
by AP-7 (Paired t test, P < 0.001, Figure 22). The behaviour observed in the
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Figure 19. Dose-response relationship of intrathecal (Lt.) $C-51322 on hair
deflection (HD)-evoked allodynia in PGE2-treated rats. Rats were pretreated
with i.t. SC-S1322 (6 ~g" 30 ~g, or 100 1-19) 15 min before Lt. PGE2 (81-19). Hair
deflection-evoked behavioural responses were rated by means of a
behavioural scoring system with the observer blinded to the nature of the
treatment. Each point represents the mean ±SEM (5-7 rats) aftha cumulative
score of HD-evoked behaviour per rat over the 2-h experimental time period,
expressed as the percent of control (no SC-51322). The solid line is the least
squares regression line and the dashed lines indicate the 95% confidence
intervals. All points were significantly different from one anotherexcept6 and
30 IJg (one-way ANOVA, P < 0.05). The slope of the linear regression line was
significantly different from 0 (slope 13" 0, one-way ANOVA, P = 0.0036).
-63-
'" ,----------------,
0' 140
::I: 120
~
~ 80
.!:! 60
~
e 20
.~
SC·51322 Dose (~g)
Figure 20. Dose-response relationship of Intrathecal (Lt.) SC·51322 on PGE2"
evoked behaviour without hair deflection (HO). Rats were pretreated with Lt.
SC-51322 (61-19, 30 1-19 or 100 1-19) fifteen min before i.t. PGE2 (81-19). Behaviour
in the absence of HD was rated using a behavioural scoring system with the
observer blinded to the nature of the treatment. Each point represents the
mean ± SEM (5-7 rats) of the cumulative score of the observed behaviour per
rat overthe 2-h experimental time period, expressed as the percent of contraI
(no SC-S1322). The solid line is the least squares regression line and the
dashed lines indicate the 95% confidence intervals. The effects of 61-19 and
100 ~g SC·51322 were significantly different from each other (Kruskal.Wallis
ANOVA on ranks, P < 0.05). The slope of the linear regression line was
significantly different from 0 (slope ~ .. 0).
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Figure 21. The time course of the inhibitory effect of AP-7 in PGE2-treated
rats. Intrathecal (Lt.) PGE2 (8 ~g) was given before (control) or twenty min
after Lt. AP-7 (0.4 ~g). Spontaneous (A) and hair deflection (HD)-evoked (8)
behaviours were rated using behavioural scoring systems with the observer
blinded to the nature of the treatment. Each column represents the mean :!:
SEM of the percent maximum possible score of 12 rats. AP-7 significantly
inhibited PGE2-induced behaviour without HD at the 19 and 29-59 min time
periods (Panel A) and HD-evoked behaviour at all time points except 10, 15,
90 and 120 min (Panel B) (Paired t-test, P < 0.05).
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Figure 22. The effect of intrathecal (Lt.) Ap·7 on PGE2..evoked behaviour with
and without hair deflection (HD). Rats were pretreated with vehicle or Ap·7
(0.4 IJg) twenty minutes before i.t. PGE2 (8 I-IQ). Behavioural responses were
rated using behavioural scoring systems with the observer blinded to the
nature aftha treatment. The cumulative score was calculated from the entire
time-course curve (120 min) for each rat (see Data Analysis; 2.3.6). Each bar
represents the mean ±SEM of 12 animals. The asterisks indicate a significant
difference from the corresponding control (Paired t·test, P <0.001).
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absence of HD stimulation was also significantly inhibited by Ap-7 pretreatment
during 16-19, 26-29, 31-34, 36-39, 1-44, 46-49, 51-54 and 56-59 min time intervals
during the 2-h experimental period (Paired t test, P < 0.05, n=12, Figure 21). The
sum of the behavioural scores per rat without HD was significantly reduced after
AP-7 (Paired t test, P < 0.001, n=12, Figure 22).
3.8 Effect of Bicuculline on Behavioural Responses in PGE2-Trealed Rats
In pilot experiments, i.t. bicuculline dose-dependently induced allodynia-like
behavioural responses in conscious rats (data not shown). After a sub-threshold
dose of Lt. bicuculline (0.01 IJg in 5 IJI saline), rats did not show any overt
behavioural changes; an HD stimulus to the lower dermatomes of the rat did not
evoke obvious behavioural agitation. This dose of bicuculline (0.01 IJg in 5 IJI
saline) was chosen for Lt. injection.
Pretreatment with this sub-threshold dose of bicuculline (0.01 IJg in 5 IJI
saline) 5 min before PGE2 enhanced PGE2-induced allodynia. Figure 238 shows
the time course of the effect of bicuculline pretreatment on the HD-evoked
behavioural responses in 8 IJg PGE2-treated rats; the percent maximum possible
score was significantly increased at all time point except 90' and 120' during the 2-h
experimental time period (Paired t test, P < 0.05). The percent maximum possible
scores for behaviour in the absence of HD stimulation was also increased during 1-
4,6-9,11-14,16-19,21-24,26-29,36-39,41-44 and 56-59 min time periods (Figure
23A).
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Figure 23. The time course of the effect of bicuculline (BIC) in PGE2·treated
rats. Intrathecal (i.t.) PGE2 (8 ~g) was given before (control) or five min after
a sub-threshold dose ofi.t. BIC (0.01 ~g), Spontaneous (A) and hair deflection
(HD)~voked (B) behaviours were rated using behavioural scoring systems
with observer blinded to the nature of the treatment. Each column represents
the mean ± SEM of the percent maximum possible score. Bicuculline
significantly enhanced PGE2-induced behaviour without HD atthe 4-29, 39, 44
and 58 min time periods (Panel A) and HD~voked behaviour at all time points
except 90 and 120 min (Panel B) (Paired t-test, P < 0.05).
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Intrathecal PGE2 (0.1 1Jg) had no effect on the spontaneous and HD-evoked
behaviour in conscious rats. After pretreatment of rats with subthreshold dose of
bicuculline (0.01 I-\g in 5 1-11 saline), intrathecal 0.1 !lg of PGE2 indeed induced
obvious behavioural responses. Figure 24 and Figure 25 show the dose-response
curve of PGE2 (with or without HD, respectively) before and after bicuculline
pretreatment. The dose response-curves of PGE2 were shifted to the left.
4 DISCUSSION
4.1 Topical Application ofBicuculline fo the Dorsal Spinal Cord Induces Localized
Allodynia
The acute blockade of spinal gtycine- or GABAA-receptors with sub-
convulsive doses of intrathecal strychnine or bicuculline, respectively, induces a
rapid, reversible and highly selective allodynic state in conscious and lightly-
anaesthetized animals (Yaksh 1989; Sherman and Loomis, 1994; Onaka et aI.,
1996). Thus, in the presence, but not absence, of i.t. strychnine or bicuculline, mild
brushing of the hair on the affected dermatomes evokes behavioural, autonomic
and neurochemical responses thai are strongly indicative of a nociceptive event.
In the present study, we have shown that bicuculline, applied locally to the surface
of the dorsal spinal cord, is equally effective in altering somatosensory processing,
but in a much more circumscribed cutaneous field (Table 1). Indeed, the ailodynia
induced by the unilateral application of bicuculline (0.1 I-Ig in 0.1 1-11 saline) to the L5
or L6 spinal segment was limited to one to two digits on the ipsilateral hind paw
(Figure 4G; Table 1). This is in sharp contrast to the bilateral and more widespread
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Figure 24. The effect of intrathecal (i.t.) bicuculline (BIC) on the dose-
response relationship of i.t. PGE2• Rats were pretreated with a sub-threshold
dose of BIC (0.01 ~g) five mIn before PGE2 (0.1, 0.8 or 8 ~g). Hair deflection-
evoked behavioural responses were rated using a behavioural scoring system
with the observer blinded to the nature of the treatment. Each point
represents the mean :t: SEM (5-7 rats) of the cumulative scores of HD-evoked
behaviour per rat over the 2-h experiment. Bicuculline significantly enhanced
the HD-evoked responses of 0.8 and 8 IJg PGE2 (Paired t-test: P =0.006 and
P = 0.012, respectively).
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Figure 25. The effect of intrathecal (Lt.) bicuculline (BIC) on the dose-
response relationship of lot. PGE2 (no hair deflection). Rats were pretreated
with a sub-threshold dose of BIC (0.01 IJg) five min before PGE2 (0.1, 0.8 or 8
IJg). Behavioural responses were rated using a behavioural scoring system
with the observer blinded to the nature of the treatment. Each point
represents the mean ±SEM (5-7 rats) ofthe cumulative scores of the observed
behaviour over the 2-h experiment. Bicuculline significantly enhanced the
behavioural responses of 0.8 and 8.0 1J9 PGE2 (Paired t test: P = 0.042 and P
= 0.049, respectively).
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sensitization of cutaneous dermatomes induced by i.t. strychnine or bicucuUine
(Table 1) (Yaksh 1989; Sherman and Loomis, 1995: Onaka et al., 1996). Allodynic
responses were evoked by hair deflection only on the affected digits of the hind
paw; they occurred without general or localized convulsive activity, and the
sensitization did not expand to the contralateral extremity over time or after
repeated bicuculline dosing (up to 6 consecutive doses every 20 min).
The magnitude of allodynia, determined from the maximum HD-evoked
responses, was dependent on the topical dose of bicuculline. These results provide
further evidence for the role of GABA in modulating low-threshold afferent input at
the spinal level, and indicate that topical bicuculline elicits allodynia by blocking
GABAA-receptors at discrete sites with the spinal segment(s) on which it is applied.
Clearty, allodynia is not the result of a generalized increase in the sensitivity to
afferent input along the spinal cord.
The localized effect of bicuculline in this study is also consistent with the
unilateral distribution of fluorescence following the topical application of a
bicuculline/bisbenzimide solution. There was no evidence of spread to the
contralateral cord after single or multiple applications. In terms of penetration into
the dorsal horn, fluorescence was highest in laminae I-III. While this fluorescence
pattern does not necessarily reflect the penetration of bicuculline into the dorsal
horn, it is noteworthy that fluorescence was highest in those laminae known to
contain the highest density of GABAA-receptors in rat spinal cord (laminae II-III;
Persohn et al. 1991), and where GABAergic terminals contact primary afferent
nerve endings (Barber et ai, 1978, Carlton and Hayes, 1990, Alvarez et al, 1992)
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or the cell bodies and dendrites of second order neurons (Barber et ai, 1978;
Magoul et al, 1987; Spike and Todd, 1992). Indeed, bicuculine, delivered into the
spinal cord of the monkey or cat by means of a microdialys)s probe placed
transversely through the mid-dorsal horn, enhanced both the background activity
and the evoked responses of spinal projection neurons (Lin et aI., 1996; Sorkin et
ai, 1998). Conversely, the delivery of GABA or the GABAA receptor agonist,
muscimol, elicited dose-dependent inhibition. These results indicate that
GABAergic neurons modulate the transfer of low threshold mechanical input from
primary afferent fibers to second order neurons in the spinal dorsal horn. That
spinal GABAergic modulation has relevance to abnormal pain stales is indicated by
the marked allodynia arising from the blockade of spinal GABAA receptors with
bicuculline (Yaksh, 1989, Onaka et ai, 1996, Loomis et ai, 2001), and by the loss
of GABA-like immunoreactive cells in lamina I-III following focal spinal cord ischemia
(Demediuk et ai, 1989; Zhang et ai, 1994; Hao et ai, 1991). Bicuculline applied to
the dorsal surface of the spinal cord appears to mimic the acute features of GABA
deficiency but in a highly site·specific and circumscribed manner.
In an effect to prolong a bicuculline effect, the drug was reapplied to the
same spot on the dorsal spinal cord every 20 min for 2 h. Allodynia was sustained
at a reproducible level throughout the experiment with no detectable change in the
size or location of cutaneous sensitization. While a similar approach is possible
using Lt. drug delivery, this is often complicated by the volume and pressure
changes introduced by repeated i.t. injections, and the attendant problem of non-
specific effects. The results of present study demonstrate the ability to induce
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highly localized and sustained allodynia using repeated topical drug administration
to the dorsal spinal corel. Sustained disinhibition will be important in determining the
immediate and delayed changes in somatosensory processing and for comparison
with changes induced by spinal cord injury.
4.2 Effect ofNS-398 on Blcucufline-Alfodynia: Evidence ofProstaglandin Synthesis
In the present study, the topical application of NS-398 to the dorsal surface
of the spinal cord dose-dependently inhibited bicuculline-allodynia. NS-398 is a
potent and selective inhibitorofCOX·2 (Copeland etal, 1994; Yamamoto, 1996b),
exhibiting a selectivity ratio (IC5(I COX-1/IC50 COX-2) of 163 in human whole blood
cells (Panara et ai, 1995), 300 in COX-1 and COX-2 transfected Chinese hamster
ovary cells (Riendeau et ai, 1997a, b) and 1263 in intact human platelets and
synovial cells (Kawai et ai, 1998) by measuring the inhibition of PGE2 production.
These data, combined with our previous report of stereo~selective inhibition of
STRYCHNINE~allodyniawith i.t. S(+) ibuprofen (Hall et aI., 1999), support the
hypothesis that PGs, synthesized and released in the rat spinal cord, facilitate the
abnormal processing of low threshold mechanoreceptive input during bicuculline·
or strychnine-disinhibition.
The synthesis of PGs from arachidonic acid is catalyzed by the enzyme COX.
There are two known isoforms of this enzyme (COX-1 and COX-2)that reside in the
membranes of the endoplasmic reticulum and nuclear envelope. Although both
have considerable sequence homology, COX-1 and COX-2 are differentially
expressed and thought to subserve different biological functions (Otto and Smith,
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1995; Herschman, 1996). COX-1 is the constitutive isoform in most tissues
including spinal cord, and is thought to be responsible for the synthesis of PGs
mediating homeostatic regUlation. Conversely, CQX-2 is primarily an inducible
isoform whose expression is triggered by a variety of chemical (e.g., growth factors,
cylokines) and electrical (depolarizing) stimuli. As SUCh, COX-2 is thought to be
responsible for the generation of PGs mediating pathogenic events. However,
CQX-2 mRNA and protein exhibited basal expression in the brain and spinal cord
(Brederet aI., 1995; Beiche et aI., 1996; Willingale et aI., 1997; Vane et aI., 1998),
suggesting that constitutive COX-2 also plays an important regulatory role within the
eNS.
This concept is supported by the results of the present study with NS-398.
Indeed, the rapid onset (5 min after topical application) and short duration of
allodynia (35-40 min) after a single dose of bicuculline (0.1 g), and the time course
of inhibition by NS-398, argue against the recruitment of inducible CQX-2 in this
experiment model. These results are in agreement with earlier reports showing
that: 1) the COX-2 selective inhibitor, celecoxib, but not the highly selective COX-1
inhibitor, SC-560, blocked the release of spinal PGs following the injection of
carrageenan into the hind paw of the rat (Smith el a!., 1998); and 2) PGD2 1eveis in
the Hippocampus of the gerbil increased -50 fold within 5 min of a seizure and
returned to near pre-seizure levels by 30 min (Forstermann et aI., 1984; Hertting
and Seregi, 1989). In addition, the restricted area of spinal cord over which the
inhibitory effects of NS-398 were observed strongly suggests that the PGs
facilitating allodynia in this model are products of COX-2 within the affected spinal
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segment(s). Whether HD ultimately triggers the expression of COX-2 during
GABAA-receptor blockade remains to be determined. However, this would
presumably require a more prolonged allodynic state (>2 h) which could be induced
with repeated bicuculline application.
4.3 Effect of AP-7 on Bicuculline-Allodynia: Role of NMDA Receptors
Pretreatment of the rat with the NMDA receptor antagonist, AP-7, markedly
suppressed the responses evoked by hair deflection during GABAA receptor
blockade. This dose-dependent effect was not due to a general depression of
spinal reflexes. Cardiovascular responses to phasic noxious pinch remained
unaltered after AP-7 (data not shown). This finding suggests that low threshold
afferent input acquires access to an NMDA receptor-dependent mechanism(s)
during GABAAreceptor blockade. It is well established that the activation of NMDA
receptors is a very important component for both hyperalgesia and mechanical or
thermal allodynia in the acute or the chronic facilitated pain animal models (Davar
et aI., 1991; Kim et aI., 1997; Khandwala et aI., 1997; Yamamoto et aI., 1996a),
while the COX-prostanoid pathway is also implicated in these abnormal pain states
(Yaksh and Malmberg, 1993; Malmberg, 1995b,c; Hay et aI., 1997). Ample
evidence demonstrated a sequential functional link between NMDA receptor
activation and the production ofprostanoids in nociceptive neurotransmission in the
spinal cord (Yaksh, 1999a). For example, in an in vitro perfusion study, PGE2 1eveis
in the perfusion medium were increased after NMDA incubation of the spinal cord
of naive rats or rats with thermal hyperalgesia after peripheral inflammation (Dirig
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and Yaksh, 1999), Intrathecal NMDA-induced mechanical allodynia and
hyperalgesia were attenuated by the NMDA receptor antagonist MK801, the COX-2
selective inhibitor DFU or NS-398 and the non-selective COX inhibitor
indomethacin, but not by the metabotropic glutamate receptor antagonist MCPG or
the non·NMDA receptor antagonists DNQX in sheep or rats (Dolan and Nelan,
1999; Yamamoto and Sakashita, 1998). Therefore, it appears that there exists an
NMDA receptor-CQX-prostagtandin pathway in the spinal nociceptive
neurotransmision (Yaksh, 1999a) and that spinal bicuculline induces allodynia, at
least in part, through prostaglandin release (Fig 2).
GABA" receptors are distributed throughout rat spinal cord dorsal horn,
especially, abundant in laminae 11·111 (Persohn et al. 1991). GABAergic neurons are
presynaptic to primary afferent input terminals or axons of interneurons and appear
to modulate glutamate release (Persohn et al. 1991, Barber et aI., 1978, Carlton
and Hayes, 1990; Alvarez et al., 1992). In situ hybridization analysis has confirmed
the presence of GABA" receptor subunit mRNAs and protein within both small and
large diameter dorsal root ganglion cells and in spinal cord dorsal horn (Persohn et
al., 1991). As much as 30% of GABA" receptors in the spinal cord dorsal horn are
believed to be on primary afferent terminals (estimates from the effects of
rhizotomies and neonatal capsaicin). Therefore, the development of allodynia may
result from an excessive glutamate release due to a loss of GABA inhibition on the
presynaptic input. Indeed, GABA released from inhibitory intemeurons of the spinal
cord is believed to activate GABA" receptors in the afferent terminals and to reduce
transmitter release (Rudomin, 1999); intrathecal bicuculline induces a transient
-77-
glutamate release in the CSF of the rat (Ishikawa and Yaksh, 1996). On the other
hand, GABAergic neurons may produce postsynaptic inhibition by contacting the
dendrites and cell bodies of the second order neurons. Thus, the.blockade of GABA
function with bicuculline may produce a partial depolarization in the membrane of
the second order neurons and remove the MgH blockade from the NMDA receptor
ion channel. In the presence of glutamate, this partial depolarization produces a
facilitated sensitization in the spinal cord, thus, HD induces allodynia.
In a more recent study (Ishikawa et aI., 2000) using a loop dialysis catheter,
intrathecal strychnine or bicuculline yielded a touch-evoked agitation. Intrathecal
bicuculline also evoked a transient spinal release of glutamate in the 0-10 min
sample, white strychnine did not affect spinal transmitter release at any time. As
intrathecal bicuculline but not strychnine increases glutamate release, while the
allodynia of both is blocked by NMDA receptor antagonism, this furthersupports the
hypothesis that GABA{A) sites regulate presynaptic glutamate release, while glycine
regulates the excitability of neurons postsynaptic to glutamatergic terminals.
In the present study, the NMDA receptor antagonist Ap·7 dose-dependently
inhibited bicuculline-allodynia. This provides further evidence that NMDA receptor
activation mediates the facilitated sensory signal processing of bicuculline-allodynia.
4.4 Effect ofAP-7 on PGE2-Allodynia in Conscious Rats: Role ofNMDA Receptors
Experiments using conscious rats afford several advantages over
anaesthetized animal experiments. Conscious experimental animals have similar
physiological conditions to those of naive animals. This is especially important in
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studies of sensory processing and pain. In this study, PGE2-allodynia was
investigated using conscious rats.
In the present study, intrathecal injection of PGE2 to conscious rats dose-
dependently induced nociceptive-like behavioural responses to innocuous tactile
stimuli. These data agree with other studies which have shown that i.t.
administration of PGE2 caused allodynia in conscious mice (Minami et aI., 1994a,b;
1995a) and rats (Malmberg et al., 1995a). The spontaneous behavioural response
(without HO stimulation) showed a trend to increase with the PGE2 dose, however,
statistical analysis indicated that this response was not dose-dependent (the slope
of linear regression line ~ = 2.95, P = 0.066).
The mechanism(s) of this innocuous tactile stimulus evoked nociceptive-like
responses (anodynia) in PGE~-treated rats remain{s) unclear. As shown in previous
studies using HPLC and fluorescence detection method PGE2 induces an
immediate increase in glutamate and aspartate release in intrathecal dialysis
perfusate of the rat spinal cord and in the superfusion of rat spinal cord
synaptosomes. Thus, one may infer that the release of excitatory amino acid (EAA)
glutamate and aspartate represents an important mechanism in PGE2 -allodynia.
Indeed, in the present study, intrathecal pretreatment of sub-immobilization dose
of an NMOA receptor antagonist AP-7 significantly inhibited PGE~-allodynia in
conscious rats. This is consistent with other data obtained in conscious mice. Co-
administration of MK·801, a non-eompetitive NMOA receptor channel blocker, orO-
AP-5, a selective NMOA receptor antagonist, with PGE2, dose-dependently blocked
PGE2·induced allodynia. In contrast, none of these NMDA receptor antagonists
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inhibited PGF2n-aliodynia (Minami e1 aI., 1994b). These results are also supported
by the preliminary data of our laboratory showing that perfusion of lumbar spinal
cord slices with PGE2 increases glutamate release. All these results suggest a
presynaptic action of PGE2 on the primary afferent terminals.
EAA such as glutamate and aspartate have been proposed as primary
afferent neurotransmitters involved in nociception in the spinal cord (Watkins and
Evans, 1981; Salt and Hill, 1983; Merighi et aI., 1991). The results of
electrophysiologicat and immunohistochemical studies suggest that these EAAs are
involved in the neurotransmission between low-threshold afferent and dorsal horn
neurons (Kangrga and Randic, 1991; Schneider and Perl 1994). Although the
precise mechanism of allodynia induced by PG is not known at present, our results
with AP-7 suggest that the PGE2 receptor activation gives rise to an increased
spinal EAA release or prolongs the release of EAA in response to low-threshold
tactile stimuli and that spinal NMDA sites activated by the released EAA may initiate
a facilitated state of spinal sensory signal processing leading to the PGE2-induced
allodynia.
In conscious mice, post-treatment with MK-801, the NMDA receptor
antagonist, 5 min after i.t. PGE2 failed to block PGE2-allodynia (Minami et aI.,
1994b). It is suggested that this facilitated state, once activated, does not require
glutamate receptor sites. Our preliminary experiments (data not shown) suggest
that post-treatment with AP.7, 5 min after i.t. PGE2does not block innocuous tactile
stimulus-induced allodynia-like behavioural responses. These results combined
with other data from post-treatment experiments suggest that in the presence of
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PGE2, once an afferent barrage from Ap fibers has generated a threshold effect on
neuronal function, the resulting activation of glutamate receptors may cause a
series of subsequent events (e.g., the production of PGs, NO) that maintain the
established allodynia without further requirement of NMDA receptor activation.
In the present study, a low dose of AP-7 (0.4 I-Ig) was used in order to
prevent drug diffusion-induced immobilization effects. AP-7 significantly but only
partially inhibited PGE2-allodynia suggesting that the dose employed may not have
been sufficient to produce a stronger or even complete blockade of the PGE2 effect.
Another strong possibility is that PGE2-induced glutamate release may only
represent one mechanism that underlies the allodynic effect of Lt. PGE2.
An alternative mechanism of PGE2-allodynia is that PGE2 may act via
neuropeptide release. PGE2 has been shown to increase the release of substance
P and to facilitate depolarization-evoked substance P release from both dorsal root
ganglion neurons in culture (Nicol et aI., 1992) and spinal cord slices in vitro (Vasko
et aI., 1994; Vasko, 1995). Substance P and glutamate, acting at NK1- and NMDA·
receptors of dorsal horn neurons, respectively, (Wall and Woolf, 1986; Dickenson
et aI., 1997; Yaksh et aI., 1999b), elicit prolonged depolarization and initiate the
facilitated excitation state in the spinal cord. Furthermore, there is cumulative
evidence showing that PGE2 may directly increase the excitability of sensory
neurons. For example, in patch clamp studies of sensory neurons isolated from
embryonic rats and grown in culture, PGE2 enhances the excitability through the
suppression of an outward potassium currenlthat may modulate the firing threshold
for generation of the action potential (Nicol et al., 1997; Evans et al., 1999), through
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the activation of the cyclic adenosine 3',5'-monophosphate pathway. PGE2 also
enhanced the capsaicin-evoked current in rat sensory neurons (by 2- to 3-fold)
(lopshire and Nicol, 1997; 1998). Intrathecal injection of an inactive dose of PGE2
enhanced capsaicin-evoked amino acid release in the spinal cord perfusate of the
conscious rat. The hypothesis that PGE2 has a direct action on the primary afferent
terminals is also supported by the finding that PGE2 enhanced CGRP release from
the spinal cord in vitro in response to dorsal root stimulation (Andreeva and Rang,
1993). CGRP is contained exclusively in primary afferent nerve terminals in the
dorsal horn (Chung et al., 1988).
Although there is no direct evidence showing the existence of postsynaptic
PGE2 receptors in the dorsal horn, the possibility of a PGE2 postsynaptic action on
the intrinsic spinal dorsal horn neurons still cannotbeexduded. Forexample, nerve
ligation central to the ganglion (central ligation) yielded an accumulation of iloprost
binding sites (PGI2 binding sites) in the ganglion side proximal to the ligature. On
the contrary no clear accumulation of PGE2 binding sites could be demonstrated.
It is suggested that iloprost binding sites are transported from ganglion cell body to
afferent input terminals (Matsumura et aI., 1995). Thus, i!oprost binding sites may
exist at the presynaptic sites while PGE2 binding sites may exist on postsynaptic
sites as suggested by the absence of PGE2 accumulation after ligature. The
decrease of PGE2 binding sites after rhizotomy may possibly only suggest that the
expression of the binding sites is under the regulatory control of primary sensory
input (Matsumura et aI., 1992, 1995).
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Taiwo and Levine (1988) proposed another possible mechanism of PGEz
action at the spinal cord level. Intrathecal PGEz antagonized the analgesia
produced by both nucleus reticularis paragigantocellularis (NRPG) electrical
stimulation and intracerebroventricular morphine. In contrast, the NSAlDs
synergized with brain stimulation and morphine-induced analgesia. The
a-adrenergic antagonist phentolamine and the catecholaminergic selective
neurotoxin 6-hydroxydopamine (used to block tonic catecholamine neuron activity
in endogenous opioid-mediated analgesia systems) prevented the hyperalgesia
induced by intrathecal PGEz. Phentolamine did not, however, block the
hyperalgesia caused by intradermal PGEz. These results suggest that PGEzcould
block both electrical stimulation-produced analgesia and endogenous opioid
mediated analgesia by inhibiting the noradrenergic synaptic transmission in the
spinal terminals of bulbospinal noradrenergic projection neurons of this analgesia
pathway. The observations that PGE2 induced-allodynia was dose-dependently
relieved by a high dose of the Uz-adrenoceptor agonist clonidine (Minami et al.,
1994b) and that PGE2 could inhibit the synaptic release of norepinephrine in the
brain (Bergstrom et al.. 1973) provide further evidence for the hypothesis that PGE2
may act at spinal postsynaptic sites in nociceptive neurotransmission.
Collectively, PGE2 may facilitate spinal sensory neurotransmission by both
postsynaptic and presynaptic mechanisms, for example, by increasing glutamate
release from primary afferent terminals as supported by the present study, by
increasing the release of neuropeptide (the latter may in turn increase glutamate
release) or by the inhibition of opioid and adrenergic mediated analgesia
mechanisms.
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4.5 Effect of SC-51322 on Bicuculline- and PGE2,Allodynia: Role ofEP Recep/ors
There is considerable evidence that PGE2. released in the rat spinal cord in
response to noxious stimuli, is the major PG that facilitates spinal nociceptive
processing (Willingale et al., 1997; Malmberg and Yaksh, 1992a; Yang et ai, 1996;
Hay et aI., 1997; and Goppelt-Struebe and Seiche, 1997). For example,
superfusion of the lumbar spinal cord of normal rats with artificial CSF and
subsequent radioimmunoassay revealed the presence of PGE2 > PGD2, but not
PGl2 (determined by measurement of the stable metabolite, 6-keto-PGF 1'..) or
PGFw
If central PGs are relevant to the abnormal processing of sensory input
during spinal disinhibition, then their effects should be attenuated by the local
application of a PG receptor antagonist. In the present study using SC-S1322, we
have demonstrated that bicuculline-allodynia is sensitive to the effects of EP-
receptor blockade; an effect that was dose-dependent. PGE2 -allodynia was also
dose-dependently inhibited by SC-51322 in conscious PGE2-treated rats. These
data are consistent with previous studies demonstrating: a) the involvement of
spinal EP receptors in the induction of allodynia by Lt. PGE2 (Minami et aI., 1995b;
Sakai et al., 1998); b) PGE2 as the major arachidonic acid product facilitating spinal
nociceptive processing (Malmberg and Yaksh, 1994; Yang et aI., 1996; Hay et al.,
1997; and Goppelt Struebe and Seiche, 1997); and c) the high affinity of PGE2 to
EP receptors (Lawrence et aI., 1992). They are also in agreement with preliminary
experiments in our laboratory showing a significant increase in the concentration of
PGE2 in spinal microdialysis samples during but not aflerstrychnine-allodynia (Hall
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et aI., unpublished observation). These results, combined with the local inhibitory
effect of NS-398, provide further evidence that spinal PGs contribute to the cellular
events which effect bicuculline-allodynia.
At [east four subtypes of the PG E-series receptors have been identified: EP,.
EP2 , EP3, EP4 . The four PGE2 receptor subtypes couple to different major signal
transduction pathways: namely elevation of intracellular calcium (EP1), stimulation
(EP2, EP4) orinhibition of adenyly[ cyclase (EP J ). Several lines of evidence indicate
that sensory neurons express EP receptors (Sley et aI., 1998). Although (3HJPGE2
binding sites are present at a high density in rat dorsal horn of the spinal cord, the
identity of the receptor subtypes is unclear. For example, using in situ hybridization
techniques, EPJ , and to a lesser extent EP1 and EP4 receptor mRNAs have been
detected in mouse dorsal root ganglia neurons (Oida et aI., 1995; Sugimoto et aI.,
1994). EP2 mRNA was detected in the spinal dorsal horn of rats (Kawamura etal.,
1997). A recent study showed that the EP3receptor is also expressed in the spinal
cord of the rat (Seiche et aI., 1998a). Immunocytochemical staining with EPJ
antibody revealed a spatia[lyconlained expression ofEPJ IR in the superficial dorsal
horn laminae 1-1[, where the nociceptive afferent terminates (Seiche et at, 1998a).
It seems that multiple EP receptors are associated with the PGE2 action in the
sensory processing of spinal cord dorsal horn. In the present study, the EP-
receptor antagonist SC-51322 partially inhibited bicuculline·allodynia as well as
PGE2-allodynia suggesting that PGE2, at least partially, mediate this abnormal
sensory processing of allodynia. While this distortion of sensory processing
appears to be mediated by spinal EP receptors, the contribution of specific EP-
receptor subtypes remains to be determined.
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4.6 Bicuculline~ and PGE2-Allodynia
Bicuculline selectively induced an augmented excitatory state in the spinal
dorsal horn; an innocuous stimulus in the presence of bicuculline evoked allodynia.
This allodynic stale is sensitive to inhibition of COX, or blockade of EP and NMDA
receptors. These results combined with the observations that PGE2 dose
dependently induced allodynia-like behaviour in conscious rats provide further
evidence for the possible role of PGE2 in bicuculline-allodynia. These results
suggest that PGs, especially PGE2, may mediate bicuculline-allodynia via affecting
EP receptors, and that the activation of NMDA receptors is important for the
abnormal sensory processing of bicuculline-allodynia. Furthermore, in the present
study, pretreatment of bicuculline enhanced PGE2-induced allodynia as evidenced
by the leftward shift of the PGE2 dose-response curve. This result indicates that
bicuculline may act, at least partially through a PGE2 pathway; in the presence of
bicuculline, administration of PGE2 may incrementally facilitate the excitatory signal
processing and produce an additive effect.
It is obvious that there is a functional link between bicuculline-induced
disinhibition and PGE2 release. This link may include: 1) bicuculline-induced
glutamate release, 2) NMDA receptor activation, 3) activation ofa cascade of signal
transduction pathways inclUding PGE2 release. PGE2 would induce more glutamate
release and further NMDA receptor activation. This positive feedback process could
represent an important mechanism in bicuculline-allodynia and PGE2 allodynia.
There also seems to be some evidence showing the direct effect of PGE2 on
GABAergic systems. For example, in the rat brain PGE2 inhibited spontaneous
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inhibitory postsynaptic currents (IPSCs) of the rat supraoptic neurons in the
presence of tetrodotoxin, a blocker of Na' channels, suggesting that PGE2 acts
presynaptically on the GABAergic terminals to decrease GABA release (Ibrahim et
aI., 1999). In a study (Eguchi et aI., 1999) using lipocalin-type PGD synthase
deficient mice (L-PGDS-I- mice), Lt. PGE2 and bicuculline failed 10 induce tactile
allodynia. while simultaneous injection of PGE2 or BIC with a femtogram amount of
PGD2 induced allodynia in L-PGDS-I- mice to the same extent as in wild-type mice.
The PGE2 or bicuculline induced allodynia in L-PGDS-I- mice was blocked by a
PGD2 receptor antagonist given in a femtogram amount. These results combined
with the present observations that bicuculline-allodynia was markedly inhibited by
the blocking of PGE2 pathway and that bicuculline enhanced PGE2 allodynia
suggest that bicuculline and PGE2 may, at least partially, share the same signal
transduction pathways in inducing allodynia.
4.7 Summary
Increased spinal glutamatergic tone has been shown to yield a state of
facilitated transmission of both low- and high-intensity stimuli (Dougherty et aI.,
1992). Of the glutamate receptor family, spinal NMDA.receptors are especially
important as those receptors that mediate long lasting depolarization including the
phenomenon of "wind up" (Dickenson and Sullivan, 1987). Such excitation appears
to be an important spinal mechanism underlying the condition of allodynia and
hyperalgesia (Yaksh et al., 1999b, Woolf and Thompson, 1991). The present
research demonstrates that the abnormal responses evoked by input from low-
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threshold mechanoreceptive afferents in the presence of spinal bicuculline and
PGE2 are indeed sensitive to NMDA·receptor blockade by AP-7 or the EP-receptor
antagonist SC-51322. In summary, the evidence obtained in this study supports the
following conclusions:
1. Bicuculline is a modulator of non-noxious somatosensory input in the spinal
cord of the rat.
2. In the presence of spinal topical bicuculline, low threshold afferent input
selectively accesses a spinal sensitization mechanism normally activated by
nociceptive fibers.
3. Blockade of the PGE2 system by the selective COX-2 inhibitor, NS-398 or by
the EP-receptor antagonist, SC·51322 attenuates bicucultine-allodynia.
4. Intrathecal application of PGE2 dose-dependently induces nociceptive-like
behavioural responses similar to those induced by i.t. bicuculline.
5. Blockade of spinal NMDA receptors inhibits both bicuculline- and PGE2-
allodynia, and at high dose, completely inhibits bicuculline-allodynia.
6. A sub-allodynic dose of bicuculline potentiates PGE2-induced al!odynic
behavioural responses.
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